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Abstract 
Satu Viertiö. Functional Limitations and Quality of Life in Schizophrenia and Other 
Psychotic Disorders. National Institute for Health and Welfare (THL), Research 60. 
147 pages. Helsinki, Finland 2011.  
ISBN 978-952-245-463-8 (printed), ISBN 978-952-245-464-5 (pdf) 
 
The evidence of the decreased functional capacity, especially everyday functioning 
of people with psychotic disorder in clinical settings is substantial. However, there is 
not much research about it in the general population. The aim of the present study 
was to provide information on the magnitude of functional capacity problems in 
persons with psychotic disorder compared with the general population. The study 
estimated the prevalence and severity of limitations in the vision, mobility, everyday 
functioning and quality of life of persons with psychotic disorder in the Finnish 
population and determined the factors affecting them. 
 
This study is based on the Health 2000 Survey, which is a nationally representative 
survey of 8028 Finns aged 30 and older. It consisted of a home interview where the 
participants were asked about their vision, mobility, everyday functioning, social 
functioning and need and receipt of assistance. The interviewer also assessed the 
functional capacity of the interviewees. The participants were given a health 
examination at their own health centre including a detailed medical examination 
with functional capacity tests. Habitual visual acuity for near and distance was 
measured and mobility and cognitive tests were done. Health-related quality of life 
was measured with two preference-based questionnaires, the 15D and EQ-5D. The 
psychotic diagnoses of the participants were assessed in the Psychoses in Finland  
survey, a substudy of Health 2000. 
 
The everyday functioning of people with schizophrenia is studied widely, but one 
important factor, mobility has been neglected. The ability to walk and climb stairs is 
important in performing everyday tasks and helpful in maintaining social 
relationships. Persons with schizophrenia and other non-affective psychotic 
disorders, but not affective psychoses had a significantly increased risk of having 
both self-reported and test-based mobility limitations as well as weak handgrip 
strength. Schizophrenia was associated independently with mobility limitations even 
after controlling for lifestyle-related factors and chronic medical conditions.  
 
Another significant factor associated with problems in everyday functioning was 
reduced visual acuity. This was confined only to participants with schizophrenia. 
They had their vision examined significantly less often during the five years before 
the visual acuity measurement than the general population. In general, persons with 
schizophrenia and other non-affective psychotic disorder had significantly more 
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limitations in everyday functioning and deficits in verbal fluency and in memory 
than the general population. More severe negative symptoms, depressive symptoms, 
older age, verbal memory deficits, worse expressive speech and reduced distance 
vision were associated with limitations in everyday functioning.   
 
Of all the psychotic disorders, schizoaffective disorder was associated with the 
largest losses of quality of life and health-related quality of life, and bipolar I 
disorder with equal or smaller losses than schizophrenia. However, the subjective 
loss of quality of life and health-related quality of life associated with psychotic 
disorders may be smaller than the objective disability, which warrants attention. 
Depressive symptoms were the most important determinant of poor quality of life in 
all psychotic disorders.  
 
In conclusion, subjects with psychotic disorders need regular somatic health 
monitoring. Since self-reported mobility limitations were already prevalent at a 
young age in persons with schizophrenia, mental health care professionals should 
also pay attention to mobility limitations in persons with psychotic disorder. Even 
though the present study setting did not allow for the investigation of how much of 
the visual impairment was due to refractive errors, visual problems might be easily 
corrected. Also, health care workers should evaluate the overall quality of life and 
depression of subjects with psychotic disorders in order to provide them with the 
basic necessities of life. 
 
Keywords: schizophrenia, psychotic disorders, functional capacity, vision, mobility, 
everyday functioning, health-related quality of life, population-based sample 
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Tiivistelmä 
Satu Viertiö. Functional Limitations and Quality of Life in Schizophrenia and Other 
Psychotic Disorders [Skitsofreniaan ja muihin psykooseihin sairastuneiden 
toimintakyvyn rajoitukset ja elämänlaatu]. Terveyden ja hyvinvoinnin laitos (THL), 
Tutkimus 60. 147 sivua. Helsinki 2011.  
ISBN 978-952-245-463-8 (painettu), ISBN 978-952-245-464-5 (pdf) 
 
Psykoosisairauksia sairastavien toimintakykyä on tutkittu kliinisissä aineistoissa, 
mutta väestötutkimukset tästä aiheesta ovat harvinaisia. Tämän tutkimuksen tarkoi-
tuksena oli tuottaa tietoa psykoosiin sairastuneiden toimintakyvyn rajoitusten laajuu-
desta verrattuna samanikäiseen yleisväestöön. Tutkimus arvioi psykoosisairauksista 
kärsivien näkökykyä, liikkumiskykyä, arkielämän toimintoja ja elämänlaatua, niissä 
ilmenevien ongelmien esiintyvyyttä ja vakavuutta sekä ongelmiin vaikuttavia teki-
jöitä. 
 
Tämä tutkimus perustui Terveys 2000 -tutkimukseen, joka on Suomen 30 vuotta 
täyttänyttä väestöä edustava 8028 henkilön väestötutkimus. Tutkimukseen kuului 
kotikäyntihaastattelu, jossa osallistujilta kysyttiin mm. näkökyvystä, liikkumisky-
vystä, arkielämän toiminnoista, sosiaalisista toiminnoista sekä avun tarpeesta ja 
saannista. Kotikäynnin yhteydessä haastattelija teki myös oman arvionsa osallistu-
jien toimintakyvystä. Toimintakykytestit tehtiin yksityiskohtaisessa terveystarkas-
tuksessa, jossa tutkittiin mm. näkökyky, liikkumiskyky ja kognitiivinen suoriu-
tuminen. Terveyteen liittyvä elämänlaatu mitattiin 15D- ja EQ-5D-kyselyillä. 
Osallistujien psykoosidiagnoosit määritettiin Terveys 2000:n syventävänä jatkotutki-
muksena toteutetussa Psykoosit Suomessa -tutkimuksessa käyttäen DSM-IV-tauti-
luokituksen diagnostisia kriteereitä. 
 
Psykoosiin sairastuneiden liikkumiskykyä on aikaisemmin tutkittu vähän, vaikka 
rajoitukset esimerkiksi kävelemisessä ja portaiden nousussa voivat vaikeuttaa joka-
päiväisten askareitten tekemistä ja sosiaalisten suhteiden ylläpitämistä. Tutkimuk-
sessa havaittiin, että skitsofrenia ja muut ei-mielialaoireiset psykoosit olivat yhtey-
dessä sekä itse ilmoitettuihin vaikeuksiin että mitattuihin liikkumiskyvyn rajoituk-
siin, ja myös heikkoon lihasvoimaan. Mielialaoireisia psykooseja sairastavilla ei 
ollut merkittävästi enempää vaikeuksia kuin yleisväestöllä. Skitsofrenian yhteys liik-
kumiskykyvaikeuksiin oli tilastollisesti merkitsevä elämäntapatekijöiden ja kroo-
nisten sairauksien huomioon ottamisen jälkeenkin.  
 
Skitsofreniaa sairastavien lähi- ja kaukonäkö olivat huomattavasti heikommat kuin 
yleisväestössä. Tässä huolimatta he olivat käyneet näöntarkastuksissa viimeisten vii-
den vuoden aikana merkittävästi harvemmin kuin yleisväestö.  
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Skitsofreniaa ja muita ei-mielialaoireisia psykooseja sairastavilla oli huomattavasti 
enemmän rajoituksia arkielämän toiminnoissa, sanasujuvuudessa ja kielellisessä 
muistissa kuin yleisväestöllä. Vakavammat negatiiviset oireet, masennusoireet, kor-
keampi ikä, kielellisen muistin ongelmat, puheen tuottamisen ongelmat ja heiken-
tynyt kaukonäkö olivat yhteydessä vaikeuksiin jokapäiväisten askareitten tekemi-
sessä ja sosiaalisissa toiminnoissa. 
 
Psykoosisairauksista huonoin elämänlaatu oli skitsoaffektiivista häiriötä sairasta-
villa. Seuraavaksi huonoin se oli skitsofreniaa sairastavilla, sitten tyypin I kaksi-
suuntaista mielialahäiriötä sairastavilla. Psykoosisairauksista kärsivät kokivat kui-
tenkin elämänlaatunsa paremmaksi kuin toimintakykyvajausten perusteella olisi 
voinut olettaa. Ilmiötä saattaa selittää sairauteen sopeutuminen. Masennusoireet oli-
vat suurin elämänlaadun heikentymisen selittäjä.  
 
Johtopäätöksenä voidaan todeta, että psykoosisairauksia sairastavat tarvitsevat 
säännöllisiä terveystarkastuksia ja toimintakyvyn arviointia. Koska itse ilmoitettuja 
rajoituksia liikkumiskyvyssä oli jo nuorehkoilla skitsofreniaa sairastavilla, hoitavien 
henkilöiden tulee kiinnittää huomiota myös liikkumiskykyyn. Vaikka tässä tutki-
muksessa ei voitu tutkia sitä, kuinka paljon heikentynyt näkökyky johtui taitto-
virheistä, näkökyvyn ongelmat voivat joissain tapauksissa olla helposti korjattavissa 
asianmukaisilla silmälaseilla. Myös elämänlaatu ja masennuksen hoito ovat asioita, 
joihin terveydenhuollon pitää kiinnittää huomiota psykoosisairauksien hoidossa.  
 
Avainsanat: skitsofrenia, psykoottiset häiriöt, toimintakyky, näkökyky, liikkumis-
kyky, arkipäivän toimintakyky, terveyteen liittyvä elämänlaatu, väestöpohjainen 
otos
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1  Introduction 
The term functional capacity refers to the capability of performing tasks and 
activities that people find necessary or desirable in their lives. Limitations in 
functional capacity cause problems in everyday living. Physical disorders may cause 
problems in functional capacity by affecting mobility or the senses in a way that 
causes difficulties in performing everyday tasks. Increasing attention has been paid 
to the measurement of the functional capacity of people with mental illness 
(Patterson and Mausbach, 2010), but the problems are still not widely enough  
recognised in the treatment of persons with psychotic disorders.  
 
Functional capacity consists of different elements: activities of daily living (ADL), 
instrumental activities of daily living (IADL), social functioning, cognitive 
functioning, mobility and the senses, particularly vision and hearing. ADL means 
the ability to perform basic self-care functions, such as eating and getting out of bed. 
IADL functions, such as cooking and shopping, are necessary for independent 
housekeeping. Symptoms related to psychotic disorders may also complicate social 
functioning, that is the ability to function in society and with other people (San et al., 
2007). 
 
The ability to move around at home or outside of the home has a major impact on 
one’s everyday life. Chronic conditions may cause problems in walking and stair 
climbing, thereby diminishing the social environment and reducing possibilities to 
live an independent life (Bhattacharya et al., 2008). Psychotic disorders are 
associated with low muscle mass (Saarni et al., 2009), which together with 
diminished postural balance may cause problems in mobility (Rantanen et al., 1999).  
 
Eyesight is an important sense when considering coping in everyday life. Impaired 
vision is associated with problems in ADL and mobility in the general population 
(Laitinen et al., 2007, Salive et al., 1994). Vision has a significant effect on 
maintaining social relationships. (Carabellese et al., 1993) 
 
Quality of life (QoL) consists of many areas and health is only one of its 
determinants. Health-related quality of life (HRQoL) is a narrower concept than 
QoL (Saarni, 2008). It is the part of QoL that can be influenced by health and health 
care. HRQoL is often considered in terms of how it is negatively affected, with 
illness causing impairment and functional limitation and finally disability 
(Verbrugge and Jette, 1994). 
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Psychotic disorders are severe mental disorders that are associated with impairments 
in cognitive abilities as well as medical comorbidity. So-called positive symptoms, 
delusions and hallucinations, are almost invariably present in psychotic disorders 
and cause problems mainly in social functioning. Disorganised speech and 
behaviour are also common, complicating the communication with other people. 
Negative and depressive symptoms are the biggest threats to functional capacity. 
Together with cognitive deficits they have been found to be the most important 
predictors of limitations in functional capacity (Bowie et al., 2006, Harvey et al., 
2006). 
 
The main purpose of the present study was to investigate the functional capacity of 
persons with psychotic disorder in a general population and to find factors that are 
associated with functional limitations. Usually the problems of functional capacity 
are studied within the patient group, in which case it is not possible to study how 
large the reductions are compared to the population of the same age. This study was 
part of an extensive population-based survey that included a comprehensive 
assessment of the health and functional capacity of the participants. This made it 
possible to investigate the factors behind the functional limitations.  
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2 Review of the literature 
2.1 Psychotic disorders 
 
Psychotic disorders are severe mental health disorders that have impaired reality 
testing as their core feature. Psychotic symptoms include delusions, hallucinations, 
disorganised speech and bizarre or catatonic behaviour. Hallucinations and delusions 
are often called positive symptoms. So-called negative symptoms, e.g. loss of 
pleasure, loss of initiative, poverty of speech and affective blunting, are associated 
with poor functional capacity and difficulties in social relationships. The third 
dimension of symptoms is disorganisation, referring to disorganised speech and 
behaviour and inappropriate affect. (APA, 1994) 
 
In this study, psychotic disorders are examined using three diagnostic categories: 
schizophrenia, other non-affective psychotic disorders (ONAP) and affective 
psychotic disorders. The diagnostic criteria and epidemiological features of 
psychotic disorders are shortly presented below.  
2.1.1 Schizophrenia 
The diagnostic criteria of schizophrenia according to the Diagnostic and Statistical 
Manual for Mental Disorders, fourth edition (DSM-IV), are presented in Table 1. 
 
 
Table 1. DSM-IV criteria for schizophrenia 
 
A. Characteristic symptoms: Two (or more) of the following, each present for 
a significant portion of time during a 1-month period (or less if 
successfully treated): 
1. delusion 
2. hallucinations 
3. disorganised speech (e.g. frequent derailment or incoherence) 
4. grossly disorganised or catatonic behaviour 
5. negative symptoms, i.e. affective flattening, alogia, or avolition 
 
Note: Only one Criterion A symptom is required if delusions are bizarre or 
hallucinations consist of a voice keeping up a running commentary on the 
person’s behaviour or thoughts, or two or more voices conversing with each 
other. 
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B. Social/occupational dysfunction: For a significant portion of the time since 
the onset of the disturbance, one or more major areas of functioning such 
as work, interpersonal relations or self-care are markedly below the level 
achieved prior to the onset (or when the onset is in childhood or 
adolescence, failure to achieve expected level of interpersonal, academic, 
or occupational achievement). 
C. Duration: Continuous signs of the disturbance persist for at least 6 months. 
This 6-month period must include at least 1 month of symptoms (or less if 
successfully treated) that meet Criterion A (i.e. active-phase symptoms) 
and may include periods of prodromal or residual symptoms. During these 
prodromal or residual periods, the signs of the disturbance may be 
manifested by only negative symptoms or two or more symptoms listed in 
Criterion A present in an attenuated form (e.g. odd beliefs, unusual 
perceptual experiences).  
D. Schizoaffective and Mood Disorder exclusion: Schizoaffective Disorder 
and Mood Disorder With Psychotic Features have been ruled out because 
either (1) no Major Depressive, Manic or Mixed Episodes have occurred 
concurrently with the active-phase symptoms; or (2) if mood episodes have 
occurred during active-phase symptoms, their total duration has been brief 
relative to the duration of the active and residual periods. 
E. Substance/general medical condition exclusion: The disturbance is not due 
to the direct physiological effects of a substance (e.g. a drug of abuse, a 
medication) or a general medical condition. 
F. Relationship to a Pervasive Developmental Disorder: If there is a history of 
Autistic Disorder or another Pervasive Developmental Disorder, the 
additional diagnosis of Schizophrenia is made only if prominent delusions 
or hallucinations are also present for at least a month (or less if 
successfully treated). 
 
 
DSM-IV is the official diagnostic system used in the United States and DSM-IV 
criteria are the most commonly used diagnostic criteria in psychiatric research. In 
Finland and elsewhere in Europe, the official diagnostic system is the International 
Classification of Diseases, tenth revision (ICD-10) (WHO, 1993). The two systems 
are not identical in diagnosing schizophrenia. DSM-IV requires that the total 
duration of symptoms is at least six months, including one month of active 
symptoms, while ICD-10 requires only a one month period of psychotic symptoms. 
Social and occupational dysfunction is required in DSM-IV but not in ICD-10.  The 
prodromal phase of schizophrenia is not included in ICD-10, as it is in DSM-IV. 
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Schizophrenia is the most common psychotic disorder. In the Psychoses in Finland 
study (PIF) the lifetime prevalence of DSM-IV schizophrenia was 0.87% (Perälä et 
al., 2007) and in a Swedish population-based study, 0.84% (Bogren et al., 2009). 
After taking into account register diagnoses of those who did not participate in the 
PIF study, the prevalence of schizophrenia rose to one per cent (Perälä et al., 2007). 
An earlier Finnish study, the Mini-Finland health survey, found a lifetime 
prevalence of 1.3% (Lehtinen et al., 1990) according to the criteria of the Present 
State Examination, which are slightly broader than the DSM-IV criteria. A 
systematic review of prevalence studies worldwide found a lower median lifetime 
prevalence worldwide, only 0.40% (Saha et al., 2005). The incidence of 
schizophrenia peaks in young adulthood and is higher in males than in females 
before the age of 30 (Sham et al., 1994). Early age of onset is associated with greater 
functional impairment (Patterson and Mausbach, 2010). After the age of 30, the 
incidence is higher in females than in males (Sham et al., 1994).  The lifetime risk is 
higher in men than in women; a meta-analysis reported that the incidence risk ratios 
for men to develop schizophrenia relative to women was 1.31-1.42, depending on 
which studies were taken into account (Aleman et al., 2003).  
 
Schizophrenia has been described as the most severe psychotic disorder, with a 
significant effect on the person’s everyday life and functional capacity. Persons with 
schizophrenia are seldom employed full-time. In the PIF study that was based on a 
representative general population study of Finns aged 30 and over, 79.8% of those 
with schizophrenia were pensioned, compared to 32.2% of the general population 
(Perälä et al., 2007). In the Northern Finland 1966 birth cohort, 54% of persons with 
schizophrenia were either on disability pension or on sick leave at the age of 35 
(Lauronen et al., 2007). Labour market outcomes differ between countries and tends 
to be worse in developed than in developing countries (Marwaha and Johnson, 
2004). However, occupational status varies greatly also in low- and middle-income 
countries (Cohen et al., 2008). 
 
Schizophrenia also leads to deficits in social functioning, one indication of which is 
that people with schizophrenia are less often married than the general population. In 
a Finnish study of 2221 hospital-discharged patients, 11% of the patients were 
married and 17% were divorced or separated (Salokangas et al., 2006a). In the PIF 
study 19.6% of people with schizophrenia were married or cohabiting, while 56.5% 
had never been married (Perälä et al., 2008). In a cross-sectional multicentre study 
covering all the Nordic countries, where the mean duration of illness was 15 years, 
70% were living independently, while 26% were living in supported housing 
(Hansson et al., 2002). According to the World Health Organisation (WHO) ten-
country study, fewer patients live alone in developing countries than in 
industrialised countries. The same study showed that the marital status of persons 
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with schizophrenia also varies greatly between countries (from 5% to 48% of men 
were married and from 22% to 76% of women) (Jablensky et al., 1992).   
 
Schizophrenia tends to be regarded as a lifetime chronic illness. This is reflected in 
the fact that there are no established criteria for recovery from schizophrenia. The 
symptom-based criteria for remission were published a few years ago (Andreasen et 
al., 2005, van Os et al., 2006), but recovery is a broader concept. Recovery means 
the ability to function in society (ability to work and have social relationships) and 
being relatively symptom-free, which is still not yet common. Defining good and 
poor outcomes is not straightforward, but both of the dimensions – that is psychiatric 
symptoms and functioning – are needed in understanding the outcome (Lipkovich et 
al., 2009). The prognosis of schizophrenia and related disorders depends on the 
social and cultural environment. In developing countries (in Africa, Asia and Latin 
America) persons with psychotic disorder have better functional outcomes than in 
industrial countries (mainly Europe and the USA) (Hopper and Wanderling, 2000). 
2.1.2 Other non-affective psychotic disorders 
Other non-affective psychotic disorders comprise schizophreniform disorder, 
schizoaffective disorder, delusional disorder, brief psychotic disorder and psychotic 
disorder not otherwise specified.  
 
In the DSM-IV diagnostic criteria for schizoaffective disorder, it is required that a 
mood episode (major depressive, manic or mixed episode) and the active-phase 
symptoms of schizophrenia occur together and were preceded or are followed by at 
least two weeks of delusions or hallucinations without prominent mood symptoms 
(APA, 1994). The lifetime prevalence of schizoaffective disorder according to the 
PIF study is 0.32%, the prevalence being higher in women (0.47%) than in men 
(0.14%) (Perälä et al., 2007). Patients with schizoaffective disorder have better 
overall functioning than patients with schizophrenia but poorer than patients with 
bipolar disorder (Grossman et al., 1991). The clinical distinction of schizoaffective 
disorder from schizophrenia and mood disorders has raised questions in psychiatry. 
A literature review by Cheniaux et al. (2008) did not succeed in making a clear 
distinction between schizoaffective disorder patients and patients with schizophrenia 
or mood disorder. The disorders were compared according to sociodemographic 
data, family morbidity, symptomatology, other clinical data (such as age of illness 
onset, suicidal behaviour, comorbidity with substance abuse and response to drug 
treatment), dexamethasone suppression test and brain imaging. The two most 
probable interpretations of the relationship of schizoaffective disorder with 
schizophrenia and mood disorder were that patients with schizoaffective disorder are 
a heterogeneous group, with some patients resembling patients with schizophrenia 
and others resembling those with bipolar disorder, or that the disorder is a middle 
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point of a continuum between schizophrenia and mood disorder.  ICD-10 and DSM-
IV differ in their definitions of schizoaffective disorder and the reliability of the 
diagnosis is sometimes arguable (APA, 1994, WHO, 1993).  
 
The symptoms of schizophreniform disorder are identical to those of schizophrenia 
except that the total duration of the illness is at least one month but less than six 
months and impaired social or occupational functioning during some part of the 
illness is not required. Full recovery in six months is required (APA, 1994). The 
lifetime prevalence of schizophreniform disorder in the PIF study was 0.07% (Perälä 
et al., 2007); thus, in a long follow-up it is a rare disorder. It is equally prevalent 
among men and women. Only 10.5% of schizophreniform disorder diagnoses 
remained stable after 24 months in a study by Salvatore et al. (Salvatore et al., 
2009). Approximately two thirds of patients diagnosed with schizophreniform 
disorder progress to a diagnosis of schizophrenia (APA, 1994). 
 
In delusional disorder, there are one or more nonbizarre delusions that persist for at 
least one month without other active-phase symptoms of schizophrenia. Auditory or 
visual hallucinations are not allowed, but tactile or olfactory hallucinations may be 
present if they are related to the delusional theme. Apart from the direct impact of 
the delusions, psychosocial functioning is not markedly impaired. The delusions are 
not due to the direct physiological effects of a substance or a general medical 
condition (APA, 1994). Patients with delusional disorder are less frequently 
hospitalised, their outcome is better and overall symptomatology is not as severe as 
in schizophrenia, although delusional symptoms may be as severe (Suvisaari et al., 
2009). In the PIF study, the lifetime prevalence of delusional disorder was 0.18% 
(Perälä et al., 2007). 
 
A brief psychotic disorder is a disturbance that involves the presence of at least one 
of the positive psychotic symptoms: delusions, hallucinations, disorganised speech 
or grossly disorganised or catatonic behaviour. An episode lasts at least one day but 
less than one month, with a full return to premorbid level of functioning (APA, 
1994). The corresponding diagnostic group in ICD-10, acute and transient psychotic 
disorders, consist of four disorders. They differ based on how much the symptoms 
resemble schizophrenia (WHO, 1993) and are a diagnostically unstable group of 
disorders (Singh et al., 2004). Brief psychotic disorder is rare; its lifetime prevalence 
in the PIF study was 0.05% (Perälä et al., 2007). 
 
A psychotic disorder not otherwise specified (NOS) means psychotic 
symptomatology about which there is inadequate information to make a specific 
diagnosis or about which there is contradictory information. One example of this 
group comprises persistent auditory hallucinations in the absence of any other 
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symptoms. In the PIF study lifetime prevalence was 0.45% (Perälä et al., 2007). The 
prevalence estimation depends on how much information can be obtained from the 
symptoms. Psychotic disorder NOS is commonly used when there is enough 
information to confirm the presence of psychosis, but not enough information about 
factors such as the temporal relationship between affective and psychotic symptoms 
or about the possible effect of substance use on the symptoms.  
2.1.3 Affective psychotic disorders 
The third diagnostic category used in the present study is affective psychotic 
disorder, which includes major depressive disorder (MDD) with psychotic features 
and bipolar I disorder (BD I). In MDD, psychotic symptoms occur within a major 
depressive episode. Mood-congruent delusions or hallucinations (delusions of guilt, 
delusions of deserved punishment, nihilistic delusions etc.) are consistent with the 
depressive themes and mood-incongruent delusions or hallucinations (persecutory 
delusions, delusions of thought insertion, delusions of control etc.) do not have any 
apparent relationship to depressive themes (APA, 1994). The lifetime prevalence of 
MDD with psychotic features was 0.35% in this study (Perälä et al., 2007). While 
MDD is more common among women than in men (Pirkola et al., 2005, Suvisaari et 
al., 2009a), there seems to be no gender difference in the prevalence of MDD with 
psychotic features (Perälä et al., 2007). MDD with psychotic features is associated 
with worse long-term outcomes than MDD without psychotic features, such as more 
readmissions to hospital and more unnatural deaths (Lee and Murray, 1988). On the 
other hand, Coryell et al. (1987) found that outcome differences between psychotic 
and nonpsychotic depression lessen and disappear over time.  
 
The essential features of BD I are a clinical course that is characterised by the 
occurrence of one or more manic or mixed episodes. BD I can have psychotic 
features if there has been at least one manic, mixed or depressive episode with 
delusions or hallucinations according to the DSM-IV diagnostic criteria (APA, 
1994). The lifetime prevalence of BD I has varied from 0.2% to 3.3% in different 
general population studies (Grant et al., 2005, Kessler et al., 2005, Pini et al., 2005). 
In the PIF study, the lifetime prevalence was relatively low, 0.24% (Perälä et al., 
2007).  The age of onset peaks in late adolescence and declines steadily thereafter 
(Grant et al., 2005). Most studies show that BD I is equally common in men and 
women (Pini et al., 2005). Outcome in BD I is worse than in other mood disorders 
(ten Have et al., 2002), but better than in schizophrenia. In a Canadian population 
survey 42.4% of the bipolar patients were married (Schaffer et al., 2006) and in the 
Australian National Study of Low Prevalence Psychotic Disorders 27.7% were 
married and 67% were currently unemployed (Morgan et al., 2005). In a relatively 
new review the unemployment of bipolar patients varied from 13% to 74% and most 
of the patients were living independently (Huxley and Baldessarini, 2007). 
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2.2 Functional capacity  
 
Functional capacity has been represented through several kinds of models. A 
sociomedical model of disability is called the disablement process, which is based 
on the model by Nagi (1965) and further extended by Verbrugge and Jette (1994), 
among others. The model is constructed of four distinct but interrelated concepts: 
pathology, impairment, functional limitation and disability (Figure 1). Active 
pathology may generate an impairment, which is a structural abnormality in the 
body system. Functional limitations comprise one theme of this study. They are 
reductions in performing physical and mental actions in daily life. Physical actions 
include overall mobility and strengths, senses like vision and hearing and 
communication. Mental actions include cognitive and emotional functions 
(Verbrugge and Jette, 1994). Both physical and mental actions may be challenging 
for a person who has suffered from a prolonged psychotic disorder.  
 
Another main theme of this study is disability in performing activities, which refers 
to difficulty in performing social roles and tasks expected of an individual in any 
domain of life e.g. work, education, social events and self-care. In the model by 
Verbrugge and Jette (1994) functional limitations stand for the reduced capability to 
perform actions without reference to situational requirements and disability stands 
for the reduction in the ability to perform expected social role activities. Commonly 
research has concentrated on personal care (activities of daily living), keeping up the 
household (instrumental activities of daily living) and work. It is possible to study 
disability through dependency, which indicates severe difficulty and the need for 
someone’s help to do an activity. Another approach, used in the present study, is 
simple self-report or proxy report about the level of difficulty (no difficulty, some 
difficulty, a lot of difficulty or unable to do) (Verbrugge and Jette, 1994). Risk 
factors that may cause impairments are longstanding behaviours or characteristics, 
which may be socioeconomic, social, lifestyle-related, behavioural, psychological, 
environmental and biological. Intra-individual factors that affect functional 
limitations are lifestyle and behaviour changes, psychosocial characteristics and 
activity adaptations. Extra-individual factors include medical care, rehabilitation, 
medication, external support and environment.  
 
In 2001, WHO published the International Classification of Functioning, Disability, 
and Health (ICF), a classification of health-related domains, which is meant to be 
used as the international standard to describe and measure health and disability 
(WHO, 2001). ICF was preceded by the International Classification of Impairments, 
Disabilities and Handicaps (ICIDH) (WHO, 1980). These two classifications have 
different perspectives to functioning. The older version used negative terms 
(impairment, disability and handicap), whereas the newer version includes body 
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functions (e.g. sensory functions), body structures (anatomic parts of the body), 
activities (execution of tasks or actions by individuals) and participation (e.g. 
communication, mobility, self-care, domestic life, interpersonal relationships, social 
and civil life), environmental factors and personal factors. However, the 
classification is exhaustive and comprehensive and should be transformed into 
practice-friendly tools in order to be useful in clinical practice (Rauch et al., 2008). 
   
 
Figure 1. A model of the disablement process (Verbugge and Jette 1994) 
 
 
2.2.1 Limitations in functional capacity in the general population and 
their determinants 
Studies of functional limitations mostly concern elderly people. In the United States, 
disability among the elderly decreased from the 1980s to the 1990s (Bhattacharya et 
al., 2008, Freedman et al., 2002, Schoeni et al., 2001). Schoeni et al (2008) found 
that the reasons for the improvement in functional capacity were better medical care 
(treatment of cardiovascular disease, increases in cataract surgery and in knee and 
joint replacements as well as more effective medication) and socioeconomic factors 
(better education and diminishing of poverty). Functional limitations of the working-
aged population have been studied much less, but Bhattacharya et al. (2008) found 
that disability increased in younger age groups in the United States between 1984 
and 1996, mainly because of the rising prevalence of obesity and chronic diseases, 
such as hypertension and diabetes. The declining trend in disability among the 
elderly from the 1980s has now reversed and older Americans are increasingly 
Pathology Disability Impairments Functional 
limitation 
Extra-individual 
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Intra-individual 
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disabled (Seeman et al., 2010). In Finland, functional limitations in activities of 
daily living and mobility have diminished from the 1970s to year 2000. The 
proportion of people on disability pension has also declined from 1980 to 2005. 
Among working-aged Finns older than 55 years, the proportion of people who are 
on disability pension has dropped from 33.1% to 20.8% (Koskinen et al., 2006). 
 
Problems with vision are strongly associated with other functional limitations 
(Laitinen et al., 2007). Habitual VA is measured with the subject’s own spectacles, 
not with best refraction correction and high-contrast letter-tests in optimal lighting 
conditions (i.e. optimal visual acuity) (Laitinen et al., 2005). The prevalence of 
habitual visual impairment increases significantly particularly after 75 years of age 
(Laitinen et al., 2005). 81.4% of the participants in the Health 2000 Survey who 
were older than 74 years had visual acuity (VA) for distance ≥ 0.5 (VA required for 
a driving licence) compared to 99.4% of those under the age of 44. The prevalence 
of good to moderate VA for near vision (VA ≥ 0.5) among those older than 74 years 
is 83.3% compared to 99.5% among those under the age of 44. Self-reported vision 
and measured visual function correlated moderately but statistically significantly 
(r=0.27- 0.40, P<0.0001). Also, eye diseases increase with age. In the same Health 
2000 Survey, 34% of participants aged 65 and older had a cataract, 13% had 
glaucoma, 12% had age-related maculopathy and 2% had diabetic retinopathy 
(Laitinen et al., 2009).  
 
Difficulties in mobility generally increase in stages with ageing. Running may 
already be difficult in middle age, while even moving around at home may be 
challenging to persons aged 75 or older (Sainio et al., 2006). Most of the mobility 
limitations start to become more common after 65 years. Difficulties in stair 
climbing and walking are the most common form of impaired functional capacity in 
the Finnish population (Koskinen et al., 2006). In a review study, Stuck et al. (1999) 
found a large number of mediating factors to functional limitations, including 
cognitive impairment, depression, comorbidity, few social contacts, low level of 
physical activity and vision impairment. Prior exercise activity and social networks 
predicted better physical performance also in MacArthur Studies of Successful 
Aging (Seeman et al., 1995). Sainio et al. (2007) found that low education leading to 
chronic diseases, obesity, smoking and physical workload are risk factors for 
mobility limitations in the general population. In the longitudinal Maastricht Aging 
Study persons with low occupational level at baseline showed a greater functional 
decline than persons with a high occupation (Bosma et al., 2007). The effect of 
mental health problems, especially depression, has been studied in older populations 
and persons who report depressive symptoms have higher risk of functional decline 
(Bruce et al., 1994, Penninx et al., 1998). 
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Activities of daily living (ADL) are basic self-care skills necessary for independence. 
The term “activities of daily living” was introduced decades ago. The first use of the 
term is credited to at least two different sources: Deaver and Brown in 1945 (Nagi, 
1991) or Buchwald in 1949 (Collin, 1997). Instrumental activities of daily living 
(IADL) are needed for independent housekeeping and are more demanding than 
ADL. In 1969 Lawton and Brody (1969) introduced the term “instrumental activities 
of daily living” to include more complex tasks involved in domestic and community 
participation. The capability to perform ADL decreases substantially with age. 
Indexes such as ADL and IADL are generally used to measure the functional 
limitations of older adults and persons recovering from physical disabilities, such as 
accidents and big operations (Häkkinen et al., 2007, Katz et al., 1963). Chronic 
conditions like arthritis, diabetes and cerebrovascular diseases are found to be strong 
predictors of limitations in ADL, along with old age and decreased visual acuity 
(Dunlop et al., 2002).  
 
The assessment of social functioning in the general population has been rather 
scarce in Finland until recently. One reason has been the lack of suitable tools for 
assessment. In a report entitled “Use of Measures of Functional Capacity in the 
Assessment of Service Needs among Older People”, Voutilainen and Vaarama 
(2005) found that 63-80% of municipalities do not use any measure to assess social 
functioning. Social functioning is not clearly defined in the literature and various 
methods are used to measure it, such as interviews, rating scales and self-reports 
(Yager and Ehmann, 2006). Usually social functioning is measured when it is 
related to specific disorders, such as fibromyalgia, epilepsy or cancer.  
 
Cognitive functioning, its determinants and its association with functional 
limitations in the general population have been studied in children and adolescents 
(Bergen et al., 2007, Sameroff et al., 1987, Seidman et al., 2000) and in the elderly 
(Artero et al., 2001, Bosma et al., 2007), but more rarely among the working aged. 
In the longitudinal follow-up it has been found that cognitive decline over time 
without dementia increases with aging and is associated with deterioration in 
performing activities of daily living (Artero et al., 2001). A longitudinal study from 
the Netherlands found that persons with a low occupational level at baseline showed 
a greater functional decline than persons with a high occupational level, but this was 
largely explained by intellectual abilities and not by socioeconomic and 
developmental factors from early life (Bosma et al., 2007). A Scottish longitudinal 
study following participants from the age of 11 to old age found that cognitive 
functioning is stable across the lifespan and higher intelligence in early life protects 
intelligence in old age (Gow et al., 2010). Persistent depressive symptoms are an 
associated risk factor for cognitive deficits in late midlife and old age (Köhler et al., 
2010, Singh-Manoux et al., 2010). Because the age profile of populations changes as 
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life expectancy increases and fertility rates fall, the number of people with dementia 
could double in the United Kingdom and also in other western countries over the 
next 30 years (Beddington et al., 2008). This gives rise to pressure to identify 
resources to prevent the cognitive decline of the populations.    
 
Quality of life (QoL) basically refers to good life but there are no strict definitions of 
it. The multi-dimensional definition includes three dimensions in QoL: 1) subjective 
positive experience and happiness, 2) ability to function and 3) availability of certain 
lifestyles and material resources (Lehman, 1997). WHO defines QoL as individuals’ 
perceptions of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns 
(1998). Health-related quality of life (HRQoL) narrows consideration to those 
aspects of QoL that are affected positively or negatively by health and medical 
health care intervention. 
 
There are hundreds of instruments to measure QoL, though many of them are 
sparsely used (Garratt et al., 2002). Technically the measures can be disease-specific 
or generic. They can be self-reports filled by patients or structured interviews. The 
instruments used in the Health 2000 Survey are the 15D and the EQ-5D, which are 
generic self-report preference-based HRQoL measures. With generic measures it is 
possible to assess health utilities, which form the quality component of quality-
adjusted life years (QALY). Health utility is a term used in health economics. 
Utilities are values that reflect the strength of the preference that people have for 
particular health states and they are measured on an interval scale with 0 reflecting 
death and 1 reflecting perfect health (Torrance, 1987). QALYs enable the 
comparison of the cost effects of different illnesses (Dolan, 2000). The QALY is 
combined from the value of the health states and their duration and every QALY is 
equivalent to one year of life in full health (Dolan et al., 2005).  
 
HRQoL is not the same for everyone. Different people find different areas of life 
important, depending on their own illnesses and disabilities and also gender 
(Bowling, 1996). In a survey of households in Great Britain, Bowling found that 
those who reported a chronic illness considered that the most important effects of 
their illness on their lives were the ability to get out and go out shopping, being able 
to work and effects on social life.  
 
Subjective QoL means global life satisfaction as defined by the respondent. It is 
measured by asking the individual to rate their current QoL as a whole, on a visual-
analogue scale (VAS) from 0 to 10, anchored at best and worst possible QoL. 
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2.3 Functional limitations in persons with psychotic disorders 
 
Symptoms associated with psychotic disorders may cause functional limitations. 
However, many of the factors associated with decreases in functional capacity in the 
general population, such as chronic conditions, lifestyle-related factors and obesity, 
are associated with psychotic disorders as well (Bushe and Holt, 2004, Cornblatt et 
al., 2007, Marder et al., 2004, Perälä et al., 2008). In addition, treatment may also 
sometimes have a negative effect on functioning. Antipsychotic medication may 
cause side effects that affect functioning and prolonged hospitalisations may also 
decrease functional capacity. All these factors may have a notable effect on 
functional capacity in an individual with a psychotic disorder.  
 
Negative, positive and disorganised symptoms are manifestations of schizophrenia 
and other psychotic disorders, and all of them may have unfavourable effects on 
functioning. Cognitive deficits are also common and may complicate everyday 
functioning. Their effect on functional capacity will be reviewed in more detail in 
Chapters 2.3.4 – 2.3.6. 
 
Psychotic disorders are commonly associated with general medical comorbidity 
(Marder et al., 2004). Cardiovascular diseases (Suvisaari et al., 2010, Fusar-Poli et 
al., 2009), diabetes (Suvisaari et al., 2008, Bushe and Holt, 2004) and metabolic 
syndrome (De Hert et al., 2009, John et al., 2009, Suvisaari et al., 2007) are more 
common in people with schizophrenia and other psychotic disorders than in the 
general population. Although psychosis is associated with numerous physical health 
problems, many patients do not get adequate treatment for physical health problems 
(Nasrallah et al., 2006). Druss et al (2001) showed that the quality of medical care is 
lower in patients with schizophrenia and their excess death rate to myocardial 
infarction could decline with better medical care.  
 
People with psychotic disorders often have an unhealthy lifestyle. Their diet 
contains more fat and less fibre than in the general population (Brown et al., 1999). 
Smoking is more common (Salokangas et al., 2006b) and exercise infrequent (Roick 
et al., 2007). Smoking is one of the major causes of excess mortality in these 
disorders (Brown et al., 2010). An unhealthy lifestyle and the side effects of 
antipsychotic medication contribute to the high prevalence of obesity in persons 
with psychotic disorder (Saarni et al., 2009), which in turn may affect functional 
capacity.  
 
The side effects of antipsychotic medication may also contribute to functional 
limitations. Antipsychotics – both typical and atypical – are associated with body 
weight gain (Allison et al., 1999), although there are significant differences in long-
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term weight gain among atypical antipsychotics (Parsons et al., 2009). Salokangas et 
al. (2007) found that low body mass index (BMI<25) was associated with poor 
functioning in men. Nevertheless, obese individuals tend to have worse physical 
functioning and general health (Strassnig et al., 2003). 
 
Extrapyramidal symptoms are common side effects, particularly of typical 
antipsychotics and may cause functional limitations. Extrapyramidal side effects are 
related to the dopamine receptor antagonism of antipsychotic medication (Marder et 
al., 2004). The most common acute expressions are akathisia, which appears as 
restlessness, and acute dystonia, which means episodic, prolonged spasms of the 
muscles of the head and the neck. Symptoms of Parkinson’s syndrome, such as 
rigidity, bradykinesia, shuffling gait and tremor, may occur during the first 5 to 30 
days of treatment when the dosage is high. Chronic extrapyramidal syndrome, 
tardive dyskinesia, may occur following prolonged antipsychotic treatment. In 
tardive dyskinesia, patients may have repetitive, involuntary and purposeless mouth 
and tongue movements, facial grimacing and rapid eye blinking or irregular 
movements of the limbs (Saddock et al., 2009). Extrapyramidal side effects can 
increase the stigma associated with schizophrenia, as they can cause patients to 
appear peculiar and make social interaction difficult (Marder et al., 2004). Some 
atypical antipsychotics (clozapine, risperidone and ziprasidone) have been found to 
have a positive therapeutic impact on psychosocial outcome in a review of 31 
studies (Corrigan et al., 2003). However, a randomised controlled trial of the effect 
on QoL, comparing atypical (other than clozapine) and typical antipsychotics found 
no disadvantage in using typical rather than atypical antipsychotics, despite the 
hypothesis (Jones et al., 2006). 
 
Most of the patients with schizophrenia usually spend at least some time in hospital, 
some even for years. A longitudinal study followed discharged patients with 
schizophrenia for up to 45 months and found that patients with longer stays 
performed worse in everyday tasks and socially (Harvey et al., 2010a). 
Deinstitutionalisation is the process of discharging persons with severe mental 
health problems from long-stay psychiatric hospitals to community mental health 
services. In Finland this process has been one of the fastest in the world and has 
posed challenges to the mental health care system (Salokangas and Saarinen, 1998). 
Patients discharged at the beginning of the 1990s were older, more disturbed and 
had been ill for a longer time than patients discharged in the early 1980s. At three 
years follow-up they also were more impaired in ADL and more often on disability 
pension and their social withdrawal had increased, but they were living more often 
independently (Honkonen et al., 1999). A later study by Honkonen et al. (2007) 
showed that the competitive employment rate of discharged patients with 
schizophrenia declined in the 1990s. The results from a Finnish series of studies 
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concerning psychiatric services in the early 1990s stress the importance of more 
targeted, active and home-based services for the most severely ill psychiatric 
patients (Korkeila, 1998). Deinstitutionalisation also requires good co-operation 
between the psychiatric services and primary health care (Korkeila, 1998).  
2.3.1 Measurement of functional capacity in persons with psychotic 
disorder 
Measuring the functional capacity of individuals may be challenging and it is 
difficult or even impossible to perfectly measure actual performance in the real 
world. Several measures of functional capacity have been developed for use with 
individuals with psychotic disorder, but a “gold standard” instrument for measuring 
functioning has not been generated (Mausbach et al., 2009). Most of the indexes that 
measure skills needed to function independently measure ADL, IADL and social 
functioning. Sensory functions and mobility are usually not part of everyday 
functioning in these indexes. Table 2 reviews several instruments of functional 
capacity. 
 
 
Table 2. Review of functional assessment instruments   
 
Instrument Abbreviation Author Description 
The Index of Activities 
of Daily Living 
ADL (Katz et al., 1963) Originally direct observation of 
independence in feeding, dressing, 
bathing, going to toilet, transfer 
and continence made by 
professional observers. Also self-
report. 
Instrumental Activities 
of Daily Living 
IADL (Lawton and Brody, 
1969) 
Rating of independence in ability 
to use telephone, shopping, 
cooking, housekeeping, laundering, 
transportation, medication and 
finance by professional observers, 
with assistance from the family, 
friends or institutional employees. 
Levels of Functioning LOF (Strauss and 
Carpenter, 1972) 
Clinician-administered rating to 
assess the duration of non-
hospitalisation for psychiatric 
disorders, frequency and quality of 
social contacts, quantity and 
quality of useful work, absence of 
symptoms, ability to meet one’s 
own needs, and fullness of life. 
Behavioral 
Assertiveness Test-
Revised 
BAT-R (Eisler et al., 1975) Measures assertive behaviour 
across multiple role-play scenes. 
Administered in a studio arranged 
as a living room. 
Social Adjustment Scale  SAS (Weissman, 1978) 45-min interview to assess 
community functioning, family 
functioning, interpersonal relations 
and work. 
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Psychogeriatric 
Dependency Rating 
Scales 
PGDRS (Wilkinson and 
Graham-White, 
1980) 
42-item scale to assess three 
dimensions of mental health: 
orientation, behaviour and physical 
capacity. Assessment by clinician. 
Specific Level of 
Function Scale 
SLOF (Schneider and 
Struening, 1983) 
Caretaker report of a patient’s 
behaviour and functioning in 
physical functioning, personal care 
skills, interpersonal skills, social 
acceptability, community activities 
and work skills. 
Independent Living 
Skills Survey 
ILSS-I (Wallace, 1986) Assesses 12 areas of skills 
personal hygiene, appearance and 
care of clothing, care of personal 
possessions and living space, food 
preparation, care of one's own 
health and safety, money 
management, transportation, leisure 
and recreational activities, job 
seeking, job maintenance, eating 
behaviours, and social interactions. 
Report by a knowledgeable 
informant. 
Independent Living 
Skills Survey Self 
Report 
ILSS-SR  Simplified version of the ILSS-I 
suitable for busy clinical settings. 
20-30-minute questionnaire. An 
interview version for individuals 
who have reading difficulties. 
Direct Assessment of 
Functional Status 
DAFS (Loewenstein et al., 
1989) 
Performance-based measure for 
evaluating everyday functioning 
with seven simulated daily 
activities: time orientation, 
communication, transportation, 
finance, shopping, grooming and 
eating 
The Life Skills Profile LSP (Rosen et al., 1989) 39-items, 5 scales: self-care, 
nonturbulence, social contact, 
communication and responsibility. 
Can be completed by family 
members, community house 
managers and professional staff  
Social Functioning Scale SFS (Birchwood et al., 
1990) 
Seven-scale self-report 
questionnaire covering social 
interaction, participation in 
community activities, independent 
living and work functioning. 
Functional Needs 
Assessment 
FNA (Bombrowski et al., 
1990) 
Assesses basic ADL, including 
self-care and care of living quarters 
based upon performance in front of 
an examiner. 
Maryland Assessment of 
Social Competence 
MASC (Bellack et al., 1994) Performance-based measure with 
four skill domains: performing 
problem-solving behaviours in an 
interpersonal context, generating 
responses to social problem 
situations, evaluating the 
effectiveness of responses and 
evaluating the effectiveness of 
one’s own problem-solving 
behaviour. 
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Mulnomah Community 
Abilities Scale 
MCAS (Barker et al., 1994) 17-item instrument rated by the 
clinician on the basis of an 
interview with the patient: assesses 
social competence, behavioural 
problems, independent living skills 
and overall adjustment to 
community living. 
Social-Adaptive 
Functioning Evaluation 
SAFE (Harvey et al., 1997) 17 items measuring social-
interpersonal, instrumental, and life 
skills functioning. Rated by 
observation, caregiver contact and 
interaction with the subject. 
Test of Grocery Store 
Shopping 
TOGSS (Hamera and Brown, 
2000) 
Evaluates the outcome of grocery 
shopping intervention in an actual 
grocery store and includes 10 
grocery items. 
Social Skills 
Performance Assessment 
SSPA (Patterson et al., 
2001b) 
A role-play instrument that 
evaluates social functioning across 
meeting a new neighbour and 
asking a landlord for assistance 
with a leaky ceiling.  
UCSD Performance-
Based Assessment 
UPSA (Patterson et al., 
2001a) 
Role plays that assess skills in five 
areas: household chores, 
communication, finance, 
transportation and planning 
recreational activities.  
Multidimensional Scale 
of Independent 
Functioning 
MSIF (Jaeger et al., 2003) Semistructured interview with the 
patient and family members, 
employers, rehabilitation and 
housing counsellors and clinical 
staff. Rates independent 
functioning in work, education and 
residential domains and provided in 
dimensions of role position, 
support and performance. 
Brief Scale of Everyday 
Functioning 
UPSA-Brief (Mausbach et al., 
2007) 
Two subscales (communication 
and finance) from UPSA 
 
 
Direct observation of a patient’s activities in natural settings appears to be the best 
way to assess functioning. However, it has disadvantages too. As the observer has to 
follow the patient’s activities throughout his or her daily routine, it is time 
consuming and demanding (McKibbin et al., 2004b). 
 
In self-report, the interviewer asks the patient to assess his or her own functioning. 
It is a simple, inexpensive and time-saving method. However, it has also been 
criticised because it may be influenced by the possible poor insight and decreased 
cognitive functioning of patients with psychotic disorder (Atkinson et al., 1997). The 
reliability of the results may be problematic. Some patients may underestimate and 
others overestimate their real-world performance. In a study by Bowie et al. (2007), 
accurate self-raters had better social skills than both underestimators and 
overestimators, and overestimators were the ones who had the greatest cognitive and 
functional impairments. Self-report is sometimes the only way to assess functioning 
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in areas where usually only the patient has access. Katz’s index is an instrument that 
can be used both for self-report and in direct observation (Rush et al., 2000). 
 
Proxy report by a caregiver may differ significantly from the self-report of the 
patient. Sainfort et al. (1996) found that patients and health providers had moderate 
agreement on symptoms and function, but little to no agreement on social relations 
and occupation. Sometimes the reason for these differences is the patient’s poor 
insight; also when the caregiver does not know the patient well enough, he or she 
might not observe the behaviour of the patients correctly. Family members’ ratings 
are usually closer to the patient’s ratings than a non-relative proxy’s (Becchi et al., 
2004). 
 
In their review, McKibbin et al. (2004b) found eight performance-based 
assessment instruments, that have been used in assessing the functional capacity of 
patients with schizophrenia. Seven of them measure activities that are addressed in 
the present study too, like household management, transportation, communication, 
eating, grooming and social skills. One of them, the UCSD Performance-Based 
Assessment (UPSA) (Patterson et al., 2001a) is the most widely used instrument in 
the research literature and is sometimes considered to be the best measure 
(Mausbach et al., 2009). Performance-based instruments measure functional 
capacity in a controlled situation. They are often performed as role-plays where the 
observer plays the role of a neighbour or someone else with whom the patient should 
deal with, or they may include tasks like going to the grocery store or preparing a 
meal. Performance-based instruments are less dependent on the patient’s insight. 
Nevertheless, because of the controlled situation, these measures may not correlate 
perfectly with actual functioning in daily life.  
 
A semistructured interview with a patient belongs to a new generation of 
instruments for the assessment of real-world functioning in schizophrenia (Miles et 
al., 2010). Interviews with family members, employers, rehabilitation and housing 
counsellors and clinical staff are also used to obtain a more accurate picture of the 
functional capacity of the patient. Ratings are calculated for three environments 
(work, education and residential) and for each of the three domains (role position, 
support and performance). Interaction between interviewer and participant may have 
a certain effect, especially when the interview is long. The characteristics of the 
interviewer, e.g. age and gender, the personal interaction between the interviewer 
and respondent and the behaviour of the interviewer may have an impact (Maynard 
et al., 2002).  
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2.3.2 Visual acuity 
Problems in visual acuity (VA) among people with severe mental illness have been 
studied since the 1950s. Unfortunately, many of the early studies had 
methodological weaknesses, such a control group that was not defined properly or 
the lack of a control group, psychiatric diagnoses were assessed inaccurately or 
visual acuity was measured inexactly (Prager and Jeste, 1993). One of the first 
studies found that the VA of persons with psychotic disorder was not worse than that 
of the non-psychotic controls (Wolin et al., 1964), but later studies have shown that 
reduced VA is more common among persons with psychotic disorder than among 
the non-psychotic (Punukollu and Phelan, 2006, Smith et al., 1997, Ungvari et al., 
2002). Nevertheless, difficulties in VA still seem to be under-recognised and often 
untreated in persons with a psychotic disorder (Punukollu and Phelan, 2006). Some 
antipsychotics are associated with increased risk of eye diseases such as cataracts 
(Isaac et al., 1991) and retinopathy (Toler, 2004). Blurred vision is one of the 
anticholinergic side effects that can be caused by both typical and some atypical 
antipsychotics, such as clozapine, olanzapine and quetiapine (Lieberman, 2004). A 
review of studies concerning vision in psychotic disorders is presented in Table 3.  
 
Table 3. Studies and results concerning vision in psychotic disorders and other 
mental health problems 
 
Authors 
 
Study design 
and sample 
Diagnostic 
system 
VA 
measurement 
Measures of 
outcomes and 
analysed 
associations 
Results 
(Wolin et al., 
1964) 
USA 
90 psychotic 
patients 
60 controls 
Not reported Snellen chart 
Objective 
optokinetic 
technique 
 No statistical 
difference 
between study 
and control 
groups 
(Callison et 
al., 1971) 
USA 
11 male 
inpatients with 
schizophrenia 
11 mental 
defective 
patients 
No controls 
Not reported Snellen chart Visual acuity Near vision: 
18% good, 
18% fair,  64% 
poor 
Far vision: 
27% good, 
64% fair, 9% 
poor 
(Cooper and 
Porter, 1976) 
USA 
54 paranoid 
patients 
57 affective 
patients 
No controls 
Not reported Snellen chart Uncorrected VA 
for distance, 
corrected VA 
when glasses 
worn, 
VA for near 
vision, with and 
without glasses 
VA for 
distance is 
considerably 
worse in the 
paranoid 
group. No 
difference in 
near vision. 
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(Smith et al., 
1997) 
Australia 
23 inpatients 
with chronic 
schizophrenia 
No controls 
DSM-III-R Qualified 
ophthalmolog
ist examined 
VA, pupil 
dilation and 
slit lamp 
examination 
Visual acuity 
Occurrence of 
toxic side effects 
of antipsychotics 
69.5% had 
problems with 
VA requiring 
correction. 
82.6% had one 
or more ocular 
disorders 
(Ungvari et 
al., 2002) 
Hong Kong 
428 inpatients 
with mainly 
schizophrenia 
(91.1%) 
No controls 
DSM-IV  Snellen chart 
Pinhole 
method 
Distant visual 
acuity (DVA) 
75% had 
impaired  (≤ 
0.5) DVA 
39% had 
refractive error 
(myopia) 
(Punukollu 
and Phelan, 
2006) 
UK 
31 inpatients 
on acute 
general adult 
wards, 42% 
psychotic 
illness 
No controls 
ICD-10 Snellen chart 
Pinhole 
method 
Visual acuity 
Reported eye 
problem 
65% VA 6/9 or 
less 
55% reported 
eye problem 
61% had not 
been to an 
optician in 5 or 
more years 
 
 
2.3.3 Mobility 
The overall mobility of persons with psychosis has not been widely studied. Most 
studies concentrate on exercise programmes developed for persons with severe 
mental illness (Gorczynski and Faulkner, 2010). The gait disturbances of people 
with chronic psychotic disorders, such as shorter strides and smaller gait speed than 
healthy controls, may affect mobility. The biggest deficits are shown to be in 
patients treated with conventional neuroleptics (Putzhammer et al., 2004). In a 
population-based study, several chronic conditions and sociodemographic factors 
have been shown to be associated with mobility limitations (Sainio et al., 2006). 
Some of them, like obesity, cardiovascular diseases, diabetes and smoking are 
commonly associated with psychosis. People with a psychotic disorder exercise 
relatively little and this lack of strain may cause difficulties in mobility. 
 
2.3.4 Everyday functioning 
Everyday functioning relates to the skills needed to function independently. The 
functional skills that are most often assessed are ADL and IADL. Although ADL 
and IADL were originally created to measure the independence of the elderly after 
physical trauma or operation (Katz et al., 1963, Lawton and Brody, 1969) these 
instruments are also used to measure physical functioning in psychiatric disorders 
(APA, 2000b, IsHak et al., 2002). Everyday functioning is usually studied using 
outpatients with schizophrenia and healthy control groups. The functioning of 
persons with schizophrenia has been found to be worse than that of controls 
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(Klapow et al., 1997, McKibbin et al., 2004a, Sciolla et al., 2003). A review of 
cross-sectional studies concerning everyday functioning is presented in Table 4.  
 
Of symptoms in schizophrenia, negative symptoms have been most often associated 
with decreased functioning in everyday life (Evans et al., 2003, Palmer et al., 2002, 
Patterson et al., 2001b) but there is also a study of older patients with schizophrenia, 
in which the severity of symptoms, both negative and positive, was not related to 
decreased functioning, whereas extrapyramidal symptoms were (Patterson et al., 
1998). There have also been results where positive symptoms explained functioning 
as much as negative ones (Godbout et al., 2007). Also depressive symptoms have 
found to be associated with worse everyday functioning (Jin et al., 2001, Sciolla et 
al., 2003). 
 
Cognitive deficits are an important predictor of declining everyday functioning 
(Evans et al., 2003, Kurtz et al., 2001, Leung et al., 2008, McClure et al., 2007, 
Palmer et al., 2002, Patterson et al., 2001a, Patterson et al., 1998, Rempfer et al., 
2003, Sciolla et al., 2003). Cognitive deficits in psychotic disorders are reviewed in 
detail in 2.3.6. The sociodemographic variables that have been found to be 
predictors of better functioning are female gender, younger age, higher educational 
level, short duration of illness and older age at onset of illness (Hintikka et al., 1999, 
Evans et al., 2003, Patterson et al., 1998, Siegel et al., 2006). 
 
The relationship between the two most reported predictors of functional limitations 
– negative symptoms and cognitive deficits – has raised questions. It has been asked, 
whether they are caused by the same factor. Harvey et al. (2006) concluded that they 
may be separable, even if they are not totally independent. Leung et al. (2008) 
suggest that the neuropsychological status of elderly outpatients with schizophrenia 
is a bigger predictor of functional outcome than symptoms or the interaction of those 
two. Findings from a recent meta-analysis support a model in which negative 
symptoms at least partially mediate the relationship between cognition and 
functional outcome (Ventura et al., 2009). 
 
One new research frame, used mainly by Bowie et al., is confirmatory path analysis 
to examine the direct and indirect prediction of the domains of real-world 
functioning (Bowie et al., 2006, Bowie et al., 2008, Bowie et al., 2010). This 
research group uses the term “real-world functioning” instead of “everyday 
functioning” to stress the difference between functioning in optimal circumstances 
and actual functioning in everyday life. In these models they try to predict three 
domains of real-world functioning: interpersonal skills, community activities and 
work skills with functional competence (performance in a structured test), 
neuropsychological functioning and symptoms. They found that the effect of 
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neuropsychological performance was mediated through the effect of cognitive 
functioning on functional competence, which in turn predicted the real-world 
functioning. Negative symptoms predicted interpersonal skills directly, without 
mediation through functional competence. Also depressive symptoms directly 
predicted interpersonal and work skills (Bowie et al., 2006). In a later study they 
added social competence along with functional competence and specific 
neuropsychological tests. All neuropsychological domains predicted functional 
competence but only processing speed and attention/working memory predicted 
social competence (Bowie et al., 2008). When they compared schizophrenia and 
bipolar disorder, there was greater disability in schizophrenia, but cognitive deficits 
predicted worse functioning in both disorders (Bowie et al., 2010).  
 
 
Table 4. Review of cross-sectional studies and results concerning everyday 
functioning and cognitive performance in psychotic disorders 
 
Authors 
 
Study 
sample 
Diagnostic 
system 
Assessment 
of 
functioning 
Assessment of 
cognition 
Results 
(Bellack et 
al., 1989) 
USA 
58 inpatients 
with 
negative or 
non-negative  
SCH 
29 inpatients 
with BD 
16 inpatients 
with 
SCHAFF 
No controls 
DSM-III-R RTP None Negative 
schizophrenia was 
associated with poor 
social functioning. 
The three other groups 
did not differ from 
each other. 
(Dickerson 
et al., 1996) 
USA 
88 
outpatients 
with SCH or 
SCHAFF 
No controls 
DSM-III-R SFS Abstraction/flex
ibility, verbal 
IQ, spatial 
organisation, 
memory, verbal 
fluency, 
attention/conce
ntration, visual 
motor, aphasia 
Patients’ overall 
social functioning was 
best predicted by a 
combination of 
negative symptoms 
and aphasia. 
(Velligan et 
al., 1997)  
USA 
Study I: 112 
chronic 
inpatients 
with SCH or 
SCHAFF 
Study II: 41 
inpatients 
with SCH 
No controls 
SCID-P 
DSM-III-R 
FNA Orientation, 
abstracting 
ability, short-
term memory 
Symptomatology 
predicts small amount 
of ADL.  
Cognition predicted 
over 40% of the 
variance in scores on 
the FC. 
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(Harvey et 
al., 1997) 
USA 
208 geriatric 
patients with 
chronic SCH 
No controls 
DSM-III-R SAFE MMSE 
CERAD 
 
Each cognitive 
measure was 
correlated with global 
social-adaptive 
deficits, with minimal 
variation in the 
magnitude of 
correlations. 
(Harvey et 
al., 1998) 
USA 
97 chronic 
inpatients 
with SCH 
37 patients 
with SCH 
31 geriatric 
patients with 
SCH 
No controls 
DSM-III-R SAFE 
 
MMSE 
CERAD 
Cognitive impairment 
is a predictor of both 
overall outcome and 
specific adaptive 
deficits. 
Differences in 
negative symptoms 
were smaller than in 
cognitive impairment 
among the groups. 
(Patterson et 
al., 1998) 
USA 
102 
outpatients 
with SCH or 
SCHAFF 
66 controls 
 
DSM-III-R 
DSM-IV 
DAFS 
 
MMSE 
DRS 
Patients had 
significantly greater 
disability than NC 
except for grooming 
and eating. Greater 
cognitive deficits 
were related to lower 
FC. 
(Harvey et 
al., 2000) 
USA 
165 geriatric 
patients with 
SCH 
165 controls 
 
 None MMSE 
Verbal fluency, 
serial learning, 
delayed recall, 
confrontation 
naming, 
constructional 
praxis 
Patients 
underperformed NC 
by 1 to 3 standard 
deviations on 
measures of memory, 
praxis and verbal 
skills. 
(Jin et al., 
2001) 
USA 
202 
outpatients 
with SCH 
from low 
severity to 
high severity 
No controls 
DSM-III-R 
DSM-IV 
 
QWB 
IADL 
SF-36 
MMSE 
DRS 
Verbal, 
psychomotor/ 
processing 
speed, 
abstraction/cog
nitive 
flexibility, 
attention/worki
ng memory, 
retention, motor 
skills, verbal 
learning 
Patients with more 
severe depression had 
worse everyday FC, 
except for physical 
functioning and 
health-related quality 
of well-being. 
(Patterson et 
al., 2001b) 
USA 
83 patients 
with SCH or 
SCHAFF 
52 controls 
 
DSM-IV SSPA 
SAS-M 
QWB 
DAFS 
DRS Social performance 
was related to severity 
of negative symptoms 
and cognitive deficits, 
not of positive or 
depressive symptoms. 
SSPA was correlated 
with QWB and ADL, 
not to a self-reported 
measure of social 
functioning 
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(Kurtz et al., 
2001) 
USA 
93 inpatients 
with SCH 
No controls 
DSM-III-R PGDRS MMSE 
CERAD 
Patients with greater 
cognitive impairment 
had higher levels of 
rated impairment on 
the orientation and 
physical, but not 
behaviour subscale 
(Dickerson 
et al., 2001) 
USA 
74 
outpatients 
with SCH 
26 
outpatients 
with bipolar 
I disorder 
No controls 
DSM-IV SFS 
Quality of  
Life  
Interview  
Verbal and 
delayed 
memory, visuo-
spatial 
constructional, 
language, 
attention, 
aphasia, 
information 
subtest, 
sequencing 
subtest 
The groups did not 
differ significantly on 
36 of 41 measures. 
Individuals with BD 
have many social and 
cognitive deficits as 
severe as those with 
schizophrenia. 
 
(Palmer et 
al., 2002) 
USA 
83 
outpatients 
with SCH 
and 
46 controls 
 
DSM-IV DAFS 
QWB 
 
Verbal, 
psychomotor/ 
processing 
speed, 
abstraction/cog
nitive 
flexibility, 
attention/ 
working 
memory, verbal 
learning, 
delayed recall, 
motor skill 
SCH patients had 
worse FC than NC. 
Severity of negative 
symptoms was 
inversely correlated 
with FC. Worse 
cognition was 
generally associated 
with worse FC. 
(Twamley et 
al., 2002) 
USA 
111 
outpatients 
(67 SCH, 29 
SCHAFF, 14 
MDD with 
psychotic 
features, 1 
psychosis 
NOS) 
No controls 
DSM-III-R 
DSM-IV 
UPSA DRS 
Verbal ability, 
attention/ 
working 
memory, 
psycho-motor 
ability, motor 
ability, 
learning, 
abstraction/ 
cognitive 
flexibility, 
executive 
functioning 
Dementia and more 
severe negative 
symptoms were 
significantly 
associated with worse 
performance. 
Generalised cognitive 
abilities were 
associated with 
everyday FC. 
 
 
(Sciolla et 
al., 2003) 
USA 
137 
outpatients 
with SCH or 
SCHAFF 
77 controls 
 
DSM-IV DAFS 
QWB 
SF-36 
 
MMSE 
DRS 
Patients had greater 
disability than NC in 
all areas expect for 
bodily pain. Best 
predictors for being in 
the SCH group were 
physical and 
emotional functioning 
and pain. 
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(Evans et al., 
2003) 
USA 
93 
outpatients 
with SCH or 
SCHAFF 
73 controls 
 
DSM-III-R 
DSM-IV 
DAFS Speed of 
information 
processing 
/psycho-motor 
speed attention/ 
working 
memory, 
abstraction/ 
flexibility, 
learning, 
delayed recall, 
verbal, motor 
NP significantly 
predicted most 
ADL/IADL, except 
eating, time 
orientation and 
grooming. 
(Rempfer et 
al., 2003) 
USA 
73 in- and 
outpatients 
with SCH 
and 
SCHAFF 
No controls 
DSM-IV TOGSS Verbal 
memory, 
executive 
functioning, 
verbal fluency, 
sustained 
attention and 
visual motor 
skills 
Accuracy was 
associated with fewer 
perseverative 
responses, better 
verbal memory and 
faster processing 
speed. Efficiency with 
better verbal memory, 
verbal fluency, 
sustained attention 
and executive 
functioning. 
 
(McKibbin 
et al., 2004a) 
USA 
54 
outpatients 
with SCH 
22 controls 
 
DSM-IV WHODAS 
UPSA 
DRS 
 
Patients reported 
greater disability than 
NC. Disability was 
associated with 
severity of depressive 
symptoms but not 
with NP and everyday 
FC. 
(Bowie et al., 
2006) 
USA 
78 older 
ambulatory 
SCH patients 
No controls 
DSM-IV UPSA 
SLOF 
 
MMSE 
Attention, 
motor skills, 
verbal learning, 
verbal memory, 
verbal fluency, 
several aspects 
of executive 
functioning. 
NP predicted FC, 
which predicted real-
world functioning. 
Depression predicted 
interpersonal (IS) and 
work skills, while 
negative symptoms 
affected IS 
independently of other 
predictors. 
(McClure et 
al., 2007) 
USA 
181older 
ambulatory 
patients with 
SCH 
No controls 
DSM-IV UPSA 
SSPA 
Attention, 
motor skills, 
verbal learning 
and memory, 
verbal fluency, 
executive 
functioning 
Processing speed, 
episodic memory and 
executive functions 
were associated with 
UPSA, working and 
episodic memory and 
verbal fluency 
associated with social 
competence 
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(Bowie et al., 
2008) 
USA 
222 
outpatients 
with SCH 
No controls 
DSM-IV UPSA 
SSPA 
SLOF 
Attention/worki
ng memory, 
verbal memory, 
processing 
speed, 
executive 
functioning 
Both direct and 
mediated effects of 
NP on real-world 
outcomes. Only 
processing speed and 
attention/working 
memory predicted 
social competence 
(SC). SC and 
functional competence 
mediated the effects 
of NP on community 
activities and work 
skills, but only SC 
predicted 
interpersonal 
behaviours. 
(Leung et al., 
2008) 
USA 
182 
outpatients 
with SCH 
56 
outpatients 
with 
SCHAFF 
No controls 
DSM-IV UPSA 
SSPA 
SLOF 
Short and long 
delay recall, 
learning, 
recognition, 
verbal fluency, 
NP status is a better 
predictor of functional 
outcome than 
symptom status or the 
interaction of the two 
factors. 
 
 
 
(Leifker et 
al., 2009) 
USA 
194 older 
outpatients 
with SCH 
No controls 
DSM-IV UPSA 
SSPA 
SLOF 
MMSE 
Attention, 
motor skills, 
verbal learning 
and memory, 
verbal fluency, 
executive 
functioning 
For residential FC, 
everyday living skills 
were the most 
important predictor. 
Real-world disability 
is a complex array of 
ability deficits and 
symptoms. 
(Aubin et al., 
2009) 
Canada 
82 
outpatients 
with SCH 
No controls 
DSM-IV-TR ILSS 
MCAS 
Visuo-motor 
coordination 
and speed of 
response, visuo-
spatial 
associative 
memory, 
planning and 
spatial working 
memory 
Visuo-spatial 
associative learning, 
negative symptoms, 
education and 
familiarity with task 
are important factors 
for FC. Planning skills 
necessary for efficient 
task performance 
most determinant for 
community 
functioning. 
(Schennach-
Wolff et al., 
2009) 
Germany 
262 
inpatients 
with SCH 
spectrum 
disorders 
No controls 
DSM-IV GAF 
SOFAS 
SF-36 
None Younger age, 
employment, shorter 
duration of illness, 
shorter length of 
current episode, less 
suicidality and fewer 
negative symptoms 
predicted functional 
remission. 
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(Harvey et 
al., 2009) 
USA and 
Sweden 
146 Swedish 
outpatients 
and 
244 New 
York 
outpatients 
with SCH 
No controls 
DSM-IV UPSA 
SLOF 
Attention, 
verbal working 
memory, 
executive 
functioning, 
processing 
speed, verbal 
fluency, verbal 
learning 
Scores on 
performance-based 
measures of everyday 
living skills were 
similar in two 
countries, but 80% 
lived independently in 
Sweden and 46% in 
New York. 
 
(Bowie et al., 
2010) 
USA 
161 
outpatients 
with SCH 
130 with BD 
No controls 
DSM-IV UPSA-B Attention, 
verbal working 
memory, 
executive 
functioning, 
processing 
speed, verbal 
fluency 
Greater disability in 
schizophrenia. NP 
predicted worse FC in 
all outcome domains 
in both disorders. 
Results support the 
shared role of NP in 
BD and SCH in 
producing disability. 
(Miles et al., 
2010) 
Canada 
156 
outpatients 
with SCH 
and 
71 controls 
DSM-IV Validation of 
MSIF 
None Schizophrenia patients 
showed moderate to 
severe impairments. 
(Simonsen et 
al., 2010) 
Norway 
114 in- and 
outpatients 
with SCH 
spectrum 
disorder 
120 with 
bipolar 
spectrum 
disorders 
268 controls 
DSM-IV SFS 
GAF 
Verbal 
memory, 
processing 
speed, working 
memory, verbal 
fluency and 
interference 
control 
Current symptoms 
had greater 
independent 
contribution to 
functioning than NP 
across clinical groups. 
SCH=schizophrenia, BD=bipolar disorder, SCHAFF =schizoaffective disorder, NP=neuropsychology, 
FC=functional capacity, RTP=Role-play test of social skills, DRS= Dementia Rating Scale, GAF=Global 
Assessment of Functioning, MMSE=Mini Mental State Examination, QWB= The Quality of Well-Being Scale 
 
 
2.3.5 Social functioning 
According to DSM-IV-TR (APA, 2000a), social functioning includes work, 
interpersonal relations and self-care. Generally it means the ability to function in 
society and communicate with other people. There are several overlapping terms 
which are used instead of ‘social functioning’, such as ‘social adjustment’ (how a 
person conforms to social expectations), ‘social dysfunction’ (an impaired ability to 
function in society), ‘social adaptation’ (one’s ability to live in accordance with 
interpersonal, social and cultural norms) and ‘social competence’ (the overall ability 
of a person to impact favourably on the social environment) (Burns and Patrick, 
2007). Impaired social functioning is commonly associated with schizophrenia and 
it has been widely studied in recent years.  
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It is very common that persons with schizophrenia are considered as ‘odd’, unfit for 
society. Feelings of shame and blame are common in people with mental illnesses 
which are more stigmatised than other illnesses. The perceived stigma may worsen 
their social functioning. In a cross-sectional survey made in 27 countries, persons 
with schizophrenia reported the most experienced discrimination in making or 
keeping friends, from family members, in finding and keeping a job and in intimate 
relationships. This stigma was the fourth greatest in Finland (Thornicroft et al., 
2009). The social functioning of persons with psychotic disorder is increasingly 
considered an important area of research and the early detection of social disability 
is crucial. It has been found that in 57% of studied first illness-episode cases, social 
disability emerged already a few years before first admission to hospital (Häfner et 
al., 1999). Those with impaired social functioning also tend to remain impaired.  In a 
two-year follow-up  of outpatients with schizophrenia, social functioning did not 
change significantly (Dickerson et al., 1999). Lower social functioning measured in 
a prodromal phase of schizophrenia remained low later on, regardless of treatment 
(Cornblatt et al., 2007). 
 
Negative symptoms are strongly related to social functioning (Bowie et al., 2010, 
Bowie et al., 2008, Bowie et al., 2006, Breier et al., 1991, Dickerson et al., 1996, 
Green, 1996). Positive symptoms also have an influence on social functioning 
according to some studies (Breier et al., 1991), while others have not found an 
independent effect of positive symptoms on social functioning (Green, 1996, 
Patterson and Mausbach, 2010). Cognitive deficits predict social functioning as they 
predict functioning in general (Dickerson et al., 1996, Green, 1996, Laes and 
Sponheim, 2006, McClure et al., 2007, Patterson et al., 2001b). There are several 
scales for the assessment of the social functioning of persons with psychotic disorder 
(Burns and Patrick, 2007). It is important to know which tests are specific to social 
functioning and which reflect functioning in daily life more broadly (Dickinson and 
Coursey, 2002). Studies comparing social functioning in people with schizophrenia 
and bipolar I disorder have obtained mixed results. Some have found that patients in 
a stable phase with bipolar disorder and schizophrenia have a similar level of social 
functioning (Dickerson et al., 2001), while other studies comparing elderly 
outpatients have found better functioning in patients with bipolar disorder (Bartels et 
al., 1997). More severe and current negative symptoms in people with schizophrenia 
reduce social functioning when compared to people with bipolar disorder (Bellack et 
al., 1989, Simonsen et al., 2010).  
 
Deinstitutionalisation has increased the importance of assessing social outcome. 
Salokangas found in a five-year follow-up study that social and functional outcome 
was better in those men with schizophrenia who were living with their spouses, than 
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in those who were living with their parents or alone (Salokangas, 1997). In contrast, 
women’s functional state was best when they were living alone. Women living alone 
had better functioning than men, but the gender difference was reversed in patients 
living with their parents or spouses. A multi-centre study by Hansson et al. (2002) 
found that the social network of those persons with schizophrenia living 
independently, alone or with their family is better than of those living in sheltered 
housing. 
 
People with schizophrenia are seldom fully employed, although competitive 
employment is an important goal for many patients. A recent review by Tsang et al. 
(2010) listed the variables most often studied and the significant predictors of 
employment were better cognitive functioning, higher education, less negative 
symptoms, more social support and skills, younger age, better previous work history 
and availability of rehabilitation services. In the meta-analysis that was part of the 
same review, marital status was the most significant predictor, even more significant 
than work history (Tsang et al., 2010). Current or past marriage was a predictor of 
competitive employment also in a Finnish study of discharged patients (Honkonen et 
al., 2007). Another review found that previous work history is the most consistent 
predictor of employment (Marwaha and Johnson, 2004). Previous studies have 
shown that good premorbid social functioning is one predictor of good vocational 
status (MacEwan and Athawes, 1997, Mueser et al., 2001). One big obstacle to 
employment is stigmatisation, both experienced and anticipated. Although people 
with schizophrenia certainly experience discrimination in seeking a job, they may 
also adopt stigmatising views of themselves as incompetent persons (Yanos et al., 
2008). This internalised stigma or self-stigma is common and sometimes severe 
among people with schizophrenia (Brohan et al., 2010). They may also fear the loss 
of benefits and professional help (Marwaha and Johnson, 2004). 
 
Social functioning is the area of functioning where gender has the biggest impact. 
Women have more social relationships, are better educated and live independently 
more often than men (Cotton et al., 2009, Shtasel et al., 1992). This is shown already 
in first-episode patients and may be due to the earlier age of onset among men and 
their typically more severe illness course.  
 
2.3.6 Cognitive functioning 
Cognitive deficits are an important feature of schizophrenia and the individuals with 
the illness usually have impairments in a wide range of neuropsychologic domains 
(Heinrichs and Zakzanis, 1998). In a review by Heinrichs and Zakzanis (1998), the 
largest effect sizes were observed in a test assessing verbal memory, word fluency 
and attention, as well as in performance and full-scale IQ. In another review of first-
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episode schizophrenia by Mesholam-Gately et al. (2009), the largest deficits were 
found in immediate verbal memory and processing speed. Deficits in memory and 
executive functions are most often associated with functional impairments (Bowie et 
al., 2008, Godbout et al., 2007, Rempfer et al., 2003). There are plenty of 
neuropsychological tests that have been used to assess the cognitive ability of 
persons with schizophrenia and in 2008 the National Institute of Mental Health 
conference identified the cognitive domains that should be the primary focuses in 
schizophrenia research: speed of processing, attention/vigilance, working memory, 
verbal learning, visual learning, reasoning and problem solving and social cognition 
(Nuechterlein et al., 2008). Because schizophrenia is a heterogeneous disorder and 
there is variability among patients in the level of impairment, it is understandable 
that different cognitive domains are also affected in individual patients (Bowie and 
Harvey, 2005). 
 
Cognitive impairment in patients diagnosed with bipolar disorder is less severe and 
less studied than in schizophrenia (Harvey et al., 2010b). Two meta-analytic reviews 
found cognitive deficits in euthymic bipolar disorder patients in attention and 
processing speed, episodic memory and executive functions (Torres et al., 2007) and 
verbal learning, immediate and delayed verbal memory, abstraction, sustained 
attention, psychomotor speed and executive functions (Robinson et al., 2006). 
Cognitive impairment is found in both bipolar I disorder and bipolar II disorder 
patients and it is more severe among bipolar I patients (Simonsen et al., 2008). 
 
Cognitive functioning in schizoaffective disorder is also much less studied compared 
to schizophrenia. A meta-analysis comparing people with schizophrenia, 
schizoaffective disorder and affective psychoses found evidence of more cognitive 
deficits in those people with schizophrenia who have more severe negative 
symptoms, but did not find qualitative differences between the groups (Bora et al., 
2009). Schizoaffective disorder is often unstable over time and some patients might 
receive a different diagnosis later. A study by Heinrichs et al. (2008) found that 
although schizophrenia is cognitively a more severe disorder than schizoaffective 
disorder, regression analysis showed that group differences in cognitive performance 
are insufficient to separate these disorders. 
 
Cognitive deficits in other psychotic disorders have been scarcely studied. For 
example delusional disorder is infrequent in clinical settings and that has hampered 
the research on the disorder. One small study did not find statistically significant 
differences in neuropsychological measures between middle-aged and elderly 
patients with delusional disorder and schizophrenia, although the severity of 
cognitive deficits was somewhat lower in the delusional disorder group (Evans et al., 
1996) 
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2.3.7 Quality of life 
An article that was based on the Health 2000 Survey compared HRQoL in 29 
psychiatric and somatic disorders using 15D and EQ-5D, and showed that self-
reported psychotic disorder was the fifth most severe disorder, after Parkinson’s 
disease, anxiety disorders, depressive disorders and arthrosis of the hip and knee 
(Saarni et al., 2006). In the Netherlands Mental Health Survey and Incidence Study 
(NEMESIS), respondents with bipolar disorder reported significantly lower HRQoL 
scores than the general population in EQ-5D, but did not differ in the 36-item Short 
Form Health Survey (SF-36), except in the role-physical score (Hakkaart-van Roijen 
et al., 2004). The HRQoL has been studied mostly in clinical studies from which 
generalisation is difficult because the inclusion criteria vary in different studies. In 
studies where participants have been recruited from in- or outpatient units, 
participants with schizophrenia generally report lower HRQoL scores in EQ-5D than 
in the Health 2000 Survey (Knapp et al., 2008, Prieto et al., 2004). Higher EQ-5D 
scores were found in a British study of stable outpatients (Briggs et al., 2008) and in 
a German study of outpatients  (König et al., 2007). In a literature review evaluating 
HRQoL among other outcomes, eight of nine studies comparing schizophrenia with 
bipolar disorder found better HRQoL for people with bipolar disorder (Dean et al., 
2004). Another review found bipolar disorder to be either comparable to or milder 
than schizophrenia (Michalak et al., 2005). A study comparing the HRQoL of 
middle-aged and elderly community-dwelling patients with bipolar disorder and 
schizophrenia found no statistically significant differences between the diagnosis 
groups (Depp et al., 2006). 
 
Bobes and Gonzales (2006) summarised the aspects of the QoL of patients with 
schizophrenia. According to their review, the QoL of people with schizophrenia is 
lower than that of the general population and that of people with other mental 
disorders. Young age, female gender, marriage, low level of education and living 
outside of institutions are associated with better QoL, and longer length of the illness 
with worse. Negative and depressive syndromes in particular are associated with 
lower QoL. Lower side effects and the combination of pharmacological and 
therapeutic treatment improve QoL. Patients who are integrated in community 
support programmes have better QoL than those who are institutionalised. 
 
As schizophrenia is a heterogeneous disorder, the QoL of the patients is not similar. 
People with stable schizophrenia consider their QoL to be higher than their objective 
life conditions and functional disability would suggest. Schizophrenia patients in 
relapse, with extrapyramidal symptoms and severe drug side effects report much 
lower QoL (Lee et al., 2000, Sevy et al., 2001). Many studies have shown a 
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discrepancy between patients’ judgements of their well-being and clinicians’ 
assessments (Atkinson et al., 1997, Bengtsson-Tops et al., 2005, Lehman, 1983, 
Sainfort et al., 1996). However, the fact that people with schizophrenia report 
differently about their quality of life according to the stage of their illness is a sign 
of their capability to assess their situation.  
 
In a study by Koivumaa-Honkanen et al. (1996) of 1204 psychiatric out- and 
inpatients, patients with schizophrenia were less dissatisfied with their life than 
patients with MDD or anxiety disorder. Depression was the strongest correlate of 
dissatisfaction in all of them, but the studied variables had the least bearing on life 
satisfaction in schizophrenia. According to another study from the same study 
sample (Koivumaa-Honkanen et al., 1999), adding depression to the multivariate 
model removed the significance of the other correlates most widely in schizophrenia 
and the change in the model was significant only in schizophrenia. Only perceived 
social support in addition to depression remained to explain life dissatisfaction in 
schizophrenia. Decreased QoL can already be present in persons who are vulnerable 
to psychosis, meaning those who have experienced psychotic-like symptoms or who 
have a first-degree relative with a psychotic disorder or at least a 30-point drop in 
their Global Assessment of Functioning score (Svirskis et al., 2007). 
 
Hospital discharges and symptomatology used to be common outcome measures. 
They are however inadequate and simplistic, since hospital discharges may tell more 
about the mental health system than about the clinical status of the patient, and 
psychotic symptoms have a relatively low correlation with functioning or self-
reported quality of life (Becker and Diamond, 2006). Modern treatment of 
schizophrenia and other psychotic disorders demands more extensive outcome 
measures and taking the quality of life of the patients into account. When these are 
assessed with self-report measures, they reflect the patients’ own values and goals in 
life.  
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3 Aims of the study 
The aim of this study was to estimate the prevalence and severity of limitations in 
the vision, mobility, everyday functioning and quality of life of persons with 
psychotic disorder in the Finnish population and to determine the factors affecting 
them. 
 
The study consists of four original publications and the specific aims were described 
as follows: 
 
1. To investigate in the general population the prevalence of impaired 
habitual visual acuity and self-reported difficulties in vision among 
persons with different psychotic disorders. 
2. To investigate mobility limitations among subjects with psychotic disorder 
in a general population-based sample. 
3. To investigate limitations in everyday functioning and their determinants 
among subjects with psychotic disorder in a general population-based 
sample. 
4. To compare the loss of utility-based health-related quality of life and 
quality of life associated with psychotic disorders. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 THL 2011 – Research 60 49 
Functional Limitations and 
Quality of Life in Schizophrenia 
and Other Psychotic Disorders 
 
4 Material and methods 
4.1 Study design and subjects 
 
This study was based on the Health 2000 Survey, a nationwide population-based 
comprehensive survey of health and functional capacity that was carried out in 
Finland from autumn 2000 to spring 2001. The study was co-ordinated by the 
National Public Health Institute (since January 1st 2009 the National Institute for 
Health and Welfare) and several national institutes participated. It was approved by 
the ethics committee of the National Public Health Institute and the Hospital District 
of Helsinki and Uusimaa (Heistaro, 2008). 
 
The Health 2000 Survey was based on a two-stage stratified cluster sampling design, 
where mainland Finland was divided into five strata, which were the university 
hospital districts. In the first stage of sampling, 80 health centre districts were 
selected, 16 districts from each stratum. In the second stage individual persons were 
selected by systematic sampling from those districts. The strata were divided into 
two sub-strata. The 15 largest health centre districts were included in the sample, 
and the remaining 65 health centre districts were selected by systematic probability 
proportional to size sampling. The sample sizes of the 15 largest health centre 
districts were proportional to population size. In the remaining 65 health centre 
districts the sample sizes were equal within each university hospital region, so that 
the total number of persons drawn from a university hospital region was 
proportional to the corresponding population size. (Heistaro, 2008) 
 
The sample size was 8028 for people aged 30 and over living in the Finnish 
mainland. In the first phase, 6986 (87%) were interviewed at home by trained 
interviewers from Statistics Finland. The home interview included 
sociodemographic information, self-reported chronic diseases and health habits, use 
of health services, functional capacity and the need for and receipt of assistance. The 
interviewers left a basic questionnaire (Questionnaire 1) for the participants to fill in 
and bring to the health examination. The health examination took place at the 
participant’s own health centre (n=6354, 79.7%) and included a thorough health 
examination including ECG, blood pressure, spirometry, bioimpedance, heel bone 
density and other measurements (including height and weight), laboratory tests, oral 
examination, functional capacity tests and clinical examination by a physician. The 
home examination (n=416, 5.2%) comprised many of the same measurements as the 
examination proper, and an abbreviated health interview was conducted if the main 
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health interview had not been carried out. Table 5 presents the phases of the Health 
2000 examination.  
 
 
Table 5. Health 2000 examination 
 
Duration Station 
15 min Reception 
15 min ECG, blood pressure and other measurements (including height 
and weight) 
15 min Spirometry, bioimpedance and heel bone density 
15 min Laboratory tests 
15 min Oral and dental examination (Dentist) 
30 min Testing of functional capacity 
30 min Clinical examination (Physician) 
30 min Mental health interview (M-CIDI) 
15 min Final interview 
 
 
The measurement of functional capacity included measurement of visual acuity and 
hearing, handgrip strength and tests of cognitive functioning. Participants aged 55 or 
older performed chair rise and walking tests. The last part of the health examination 
was a structured computer-assisted mental health interview, the Munich version of 
the Composite International Diagnostic Interview (M-CIDI) (Wittchen et al., 1998, 
Wittchen and Pfister, 1997). Questionnaires 2 and 3 were handed to participants 
after the health examination to be filled in the examination site or filled in later and 
mailed. For those who could not participate in the health examination at their own 
health centre, including all participants living in institutions, a condensed interview 
and health examination were conducted at their homes or institutions.  
 
If a person was not able to participate in any of the abovementioned parts of the 
survey, he or she was called and those consenting were interviewed by phone 
(n=454, 5.7%). The telephone interview was based on the home health interview and 
Questionnaire 1 but was shorter. For those who had not participated in any of the 
previous stages, a questionnaire was sent by mail (n=63, 0.8%), covering the same 
topics as the telephone interview. Counted on the basis of all persons from whom at 
least part of the information was obtained, the rate of participation was 93%. All the 
questionnaires and the interviews are available at http://www.terveys2000.fi/. 
(Heistaro, 2008) 
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4.1.1 Screening and diagnostic assessment of psychotic disorders 
The mental health interview (M-CIDI) that was used in the Health 2000 Survey is 
not adequate for diagnosing psychotic disorders (Kendler et al., 1996). Because of 
that another study focusing on severe mental disorders was done between 2002 and 
2004. This study – called the Psychoses in Finland (PIF) – is a sub-study of Health 
2000. Those with a possible psychotic disorder were screened and interviewed with 
the Research Version of the Structured Clinical Interview for DSM-IV-TR (SCID-I) 
(First et al., 2001). Participants were screened to participate in the SCID interview if 
they reported a diagnosed psychotic disorder, received a diagnosis of possible or 
definite psychotic disorder from the physician conducting the health examination, 
reported possible psychotic or manic symptoms in the CIDI or had other symptoms 
suggestive of psychotic disorder. Several registers were also used in screening for 
signs of psychotic disorders among the whole study sample (Perälä et al., 2007). 
Figure 2 presents the design of the PIF Study.  
 
The positive screen findings described in detail in Perälä et al. (2007) included the 
following: 
 
The Health 2000 examination 
 77 participants who reported in the health interview that they had been 
diagnosed with psychotic disorders  
 45 participants with possible or definite psychotic disorders as assessed by 
the physician who conducted the health examination 
 
CIDI interview  
Section F screen for bipolar I disorder 
 124 participants who reported that they had had a lifetime episode of 
elevated or irritable mood lasting at least four days plus had had at least 
three manic symptoms. The current occurrence of all manic symptoms was 
not required 
Section G screen for positive psychotic symptoms 
 238 participants who reported any clinically relevant positive psychotic 
symptom (i e the symptom interfered with normal life or the person had 
discussed it with a health care professional), or at least three symptoms 
regardless of clinical relevance that may have occurred during the subject’s 
lifetime 
Section P screen for other psychotic symptoms 
 93 participants with symptoms of positive formal thought disorder, negative 
symptoms, behaviour that suggests the person is having hallucinations, or 
catatonic symptoms 
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 Four participants were selected to be re-interviewed because the interviewer 
comments on their behaviour at the interview were indicative of psychotic 
disorder 
 
Registers 
 238 participants from the National Hospital Discharge Register because of a 
diagnosis of any psychotic or bipolar disorder 
 211 participants from the Medication Reimbursement Register of the 
Finnish Social Insurance Institution because of free medication for severe 
psychotic and other severe mental disorder 
 180 participants from the Pension Register of the Finnish Centre for 
Pensions because of disability pension due to any psychotic disorder, 
bipolar disorder or major depressive disorder 
 36 participants from the Finnish National Prescription Register of the 
National Insurance Institution who used moodstabilizing medication and 
did not have any physical condition, like epilepsy, that would have 
explained its use. 
 
All case records were collected from hospital and outpatient treatments, including 
those not interviewed but excluding those who had refused to participate in the 
Health 2000 Survey. The final best-estimate diagnoses were made by three 
clinicians (Jaana Suvisaari, Jonna Perälä and Samuli I. Saarni) using DSM-IV-TR 
criteria. Of the 746 screen-positive participants, 444 were re-interviewed, while the 
rest were diagnosed based on case records alone. Kappa values between the raters 
ranged from 0.74 to 0.97 for different psychotic disorders and were either good or 
excellent regardless of whether the diagnosis was based on both the SCID interview 
and case records, or case records alone.  
 
The presence of DSM-IV schizophrenia was confirmed in 67 persons. In addition, 
there were 10 persons with a register-based diagnosis of schizophrenia who either 
had refused to participate in the study or for whom there was not enough 
information to confirm the diagnosis. The measurements used in this study were 
from 61 of these individuals, which means that the participation rate of persons with 
schizophrenia was 79.2%. Of the 105 subjects with ONAP who belonged to the 
sample, the measurements were from 79 (75.2%) individuals, and of the 51 subjects 
with affective psychotic disorder the measurements were from 45 individuals 
(88.2%). 
 
Lifetime symptoms of psychotic disorders were assessed with the Major Symptoms 
of Schizophrenia Scale (MSSS) (Kendler et al., 1993, Kendler et al., 1998). Because 
some symptoms were not covered by the MSSS, we added the global rating of 
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bizarre behaviour from the Scale for the Assessment of Positive Symptoms (SAPS) 
(Andreasen, 1984) and the global ratings of avolition-apathy and of anhedonia-
asociality from the Scale for the Assessment of Negative Symptoms (SANS) 
(Andreasen, 1982). From these ratings, summary scores were formed for positive 
symptoms (delusions and hallucinations), disorganised symptoms (positive thought 
disorder and bizarre behaviour and negative symptoms (negative thought disorder, 
avolition-apathy, anhedonia-asociality and affective deterioration). The interrater 
reliability of the symptom summary measures was assessed using intraclass 
correlations from 136 participants that had been rated by all three raters blind to 
each other’s ratings. The intraclass correlations were excellent, 0.93 for positive 
symptoms, 0.89 for negative symptoms and 0.82 for disorganised symptoms.  
 
In the present study, lifetime diagnoses of psychotic disorder were classified into 
schizophrenia, other non-affective psychotic disorder (ONAP) (schizophreniform 
disorder, schizoaffective disorder, delusional disorder, brief psychotic disorder, 
psychotic disorder not otherwise specified) and affective psychoses (major 
depressive disorder with psychotic features and bipolar I disorder).  
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Figure 2. Design of the Psychoses in Finland Study (Perälä et al. 2007). 
 
 
4.2 Socio-demographic variables 
 
The socio-demographic factors used in the analyses were age, gender and education. 
Age was used as a continuous variable in Studies I and III. In Study II age was 
categorised into two classes, 30-54 and 55-99 years, because functional capacity 
tests were done only to participants 55 years or older. In Study IV age was 
categorised as 30-44, 45-54, 55-64, 65-74, 75-85 and over 85 years. Education was 
obtained from the home interview and it was classified as basic (≤ 6 years of 
primary education), secondary (7-11 years of primary education or ≤ 6 years of 
primary education plus vocational school) and high (7-11 years of primary education 
plus vocational school, matriculation examination or a higher vocational institution 
or university) (Heistaro, 2008).  
 
Health 2000 Survey 
8028 participants 
453 from baseline study 
Self-reported psychosis (n=77) 
Psychosis assessed by physician (n=45) 
CIDI screened diagnoses (n=404) 
419 from national registers 
National Hospital Discharge Register (n=238) 
National Medication Reimbursement Register 
(n=180) 
National Pension Register (n=211) 
National Prescription Register (n=36)
746 selected by the PIF screen 
692 had final best-estimate diagnoses 
54 refused to participate at 
baseline and were not contacted or  
did not have enough information 
for diagnostic assessment 
248 had information 
only from case records 
444 interviewed with SCID  
196 had no treatments 
248 had case records 
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4.3 Measures and assessments of functional capacity 
4.3.1 Visual acuity 
As part of the health examination, habitual visual acuity (VA) for distance was 
measured binocularly at 4 m with the participant’s current glasses or contact lenses, 
if usually worn, using a modification of the logMAR letter chart published by 
Precision Vision (Ferris et al., 1982). Habitual near vision was tested with the near 
vision chart complying with the same principles as the distance VA chart. The test 
was performed at the participant’s preferred reading distance. Illumination was 
optimised to 350 lux or more on far and near vision charts (Laitinen et al., 2005).  
 
During the health interview the subjects were asked whether they had difficulties in 
reading newsprint or television subtitles, corresponding to difficulties in near and 
distance vision, using the following questions:  
 
1. Is your eyesight good enough (with glasses) to read normal newspaper print? 
2. Are you able to read television subtitles (with glasses) from a normal 
watching distance (approximately 3 metres)? 
 
In Study I, binocular VA of ≥ 0.8 was defined as good and VA of 0.5-0.63 as 
moderate VA. Visual impairment was defined as binocular VA of <0.5. Visual 
acuity of 0.32-0.4 was defined as mildly impaired VA and VA of ≤0.25 as 
moderately to severely impaired VA, including blindness (Laitinen et al., 2005). In 
Study III VA of <0.8 was defined as reduced.  
 
4.3.2 Mobility 
Self-reported functional capacity was asked in the home interview, where the 
questions on mobility were formulated as follows: “How do you nowadays manage 
the following activities?” Activities that were covered were overall mobility, 
moving about in the house, walking about 0.5 km and 2 km without resting, running 
about 100 m and about 0.5 km, climbing up one or several flights of stairs without 
resting, riding a bicycle and walking 100 m while carrying a 5 kg bag. The four 
response alternatives were: without difficulties, with minor difficulties, with major 
difficulties or not at all. The respondents were classified as having limitations if they 
reported any difficulties or were unable to perform the activity. Most questions were 
about activities required in everyday life, in which even small impairments may 
interfere with normal life. Therefore, we dichotomised variables in order to 
distinguish those who had at least some difficulties performing the activity from 
those who had no difficulties.  
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In the health examination, the tests of physical capacity were administered to 
subjects aged 55 or over. Trained study nurses supervised mobility performance 
tests. Walking ability was measured on a course of 6.1 m, which the examinee was 
advised to walk as fast as possible. Performance was considered limited if walking 
speed was below 1.2 m/s as that is the speed needed to cross the street safely 
(Langlois et al., 1997). The ability to rise from a chair was tested by asking the 
examinees to stand up from a standard-height chair without help of the arms. 
Performance in four additional tests was coded as normal or impaired: walking two 
metres on the flat, walking two metres on one’s toes, climbing two steps up and 
down and squatting.  
 
Handgrip strength was measured three times from all participants and the best value 
was recorded as the result. The results were standardised and expressed as age- and 
gender-adjusted Z-scores. The amount of exercise participants take was measured 
with the question: “How much do you exercise and strain yourself physically in your 
leisure time?”, from which we created a dichotomised variable (no exercise at all or 
at least some exercise). (Aromaa and Koskinen, 2004) 
 
4.3.3 Everyday functioning 
In the health interview participants self-reported how they managed in their 
everyday life. Questions concerning daily living were based on measures developed 
by Katz et al. (Katz et al., 1963), Lawton and Brody (Lawton and Brody, 1969), and 
the OECD (McWhinnie, 1981). In this study the activities of daily living were: 
getting in and out of bed, dressing, eating, bathing and toileting. Instrumental 
activities of daily living were shopping, cooking, laundering, heavy cleaning and 
cutting toenails. Items of social functioning were: using the phone, taking care of 
matters together with other people, communicating with strangers, dealing with the 
authorities and financial institutions and travelling on public transportation. The 
questions were formulated as follows: “How do you nowadays manage the 
following activities?” The four response alternatives were: without difficulties, with 
minor difficulties, with major difficulties or not at all. The respondents were 
classified as having limitations if they reported any difficulties or were unable to 
perform the activity and the variables were dichotomised to distinguish those who 
had at least some difficulties performing the activity from those with no difficulties. 
(Heistaro, 2008) 
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4.3.4 Cognitive functioning 
Cognitive functioning was examined in the health examination using selected tasks 
from the CERAD (The Consortium to Establish a Registry for Alzheimer’s Disease) 
cognitive test battery by a nurse trained to use this instrument. In the test of verbal 
fluency, the subjects were asked to list as many animals as possible in one minute. 
In this test, performance deteriorates due to difficulties in verbal ability, semantic 
memory and executive functions (Morris et al., 1989). In the memory test, the 
subjects were shown 10 words one after another that they were to read aloud and 
commit to memory. If the subjects failed to remember all 10 words at the first trial, 
they were shown the words two more times. Due to an error in the CERAD 
instructions that had been given to the personnel the word list was not read three 
times to those participants who immediately or in the second trial remembered all 10 
words. This was taken into account excluding these participants from the analyses. 
 
The delayed recall of the words was tested by asking the subjects to repeat the same 
list after about five minutes. Participants unable to do the test because of severe 
dementia were not tested. Participants were also asked to estimate their present 
memory and whether poor memory causes any difficulties in their everyday life. 
(Heistaro, 2008) 
 
4.3.5 Health-related and subjective quality of life 
Health-related quality of life was measured with two established, generic, self-report 
and preference-based HRQoL measures: the EQ-5D (1990) and the 15D (Sintonen, 
1994) as there is no gold standard for HRQoL measurement (Saarni et al., 2006, 
Tengs and Wallace, 2000).  
 
The 15D has 15 dimensions with five categories of severity: mobility, vision, 
hearing, breathing, sleeping, eating, speech, elimination, usual activities, mental 
function, discomfort and symptoms, depression, distress, vitality and sexual activity. 
The 15D utility index (Sintonen, 1995) ranges between 1 (full health) and 0 (death). 
Subjects with 12 or more completed 15D dimensions were included in the study, and 
missing values were predicted with linear regression analysis using the other 15D 
dimensions, with age and gender as independent variables, as recommended 
(Sintonen, 1994). Changes of over 0.02-0.03 points on the 15D are considered 
clinically significant (Sintonen, 2001). To calculate the 15D utility index, we used 
valuations elicited from the Finnish population using the multi-attribute utility 
method (Sintonen, 1995). 
 
The EQ-5D (Brooks, 1996) has five dimensions with three categories of severity: 
mobility, self-care, usual activities, pain or discomfort and anxiety or depression. 
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The most commonly used tariff, the UK time-trade-off (TTO) values were used to 
generate the EQ-5D utility index (Dolan et al., 1996, Kind et al., 1999). The EQ-5D 
TTO index ranges between 1 (full health) and -0.59 (0=death). States worse than 
death, such as vegetative states, may be given a negative value. TTO means how 
many life years the respondent would give up in order to be in full health in 
comparison to another health state. Only participants fully completing the EQ-5D 
questionnaire were included. Although there is no unequivocally agreed threshold 
for minimum clinically important change on the EQ-5D, thresholds around 0.07 
points have been suggested (Walters and Brazier, 2005). 
 
Subjective quality of life was measured by asking the participants to rate their 
current quality of life as a whole, for the last 30 days, on a scale from 0 (worst 
possible quality of life) to 10 (best possible quality of life). 
 
4.3.6 Interviewers’ assessments 
At the end of the home interview the interviewers rated their general impression 
about the participants and their homes. They rated the interviewee’s mobility 
limitations, need for help, eyesight, hearing, speech and understanding of speech and 
instructions. This information was useful because the interviewers were not health 
care professionals who are used to meeting people with mental disorders and 
therefore observed the participants from a layperson’s point of view. All the 
interviewers were professionals from Statistics Finland, who have basic training for 
the job. On average, they had 11 years of experience of professional interviewing. 
They were able to compare the living environment of a mental health patient to the 
situation of an average citizen. The fact that the interview took place at home was an 
advantage because the assessments the interviewers made were not based solely on 
the participant’s own report. (Heistaro, 2008) 
 
4.4 Statistical methods 
 
The sampling design in Studies I, II and III was accounted for by using SUDAAN 
software (version 9.0) (SUDAAN, 2004) for SAS (versions V8 and V9.1), which is 
able to take account of two-stage cluster sampling design and calculates robust 
standard error estimates. Poststratification weights estimated by Statistics Finland 
were applied to adjust for nonresponse and for the oversampling of individuals aged 
80 and over. Two-stage cluster sampling design was taken into account only in 
analyses made in the whole sample, not in the analyses made within the psychosis 
group, since there were too few participants per cluster. Some analyses were done 
with SAS version 9.1.3. (SAS, 1999) in Study II and Study III. Regression analyses 
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of Study IV were conducted using Stata 8.2 for Windows (StataCorp, 2003), and the 
other analyses using SAS 9.1.3. (SAS, 1999). Analyses accounted for the two-stage 
sampling design.  
 
4.4.1 Study I 
The prevalences of VA, self-reported eye diseases and self-reported vision problems 
among participants with different psychotic disorders and without psychotic disorder 
were calculated as percentages of the population. In each group, the prevalences of 
self-reported vs. measured problems were compared. Among persons with psychotic 
disorders, VA was compared in those who used vs. did not use antipsychotic 
medication, and in persons with vs. without comorbid type 2 diabetes. Differences 
between categorical variables were tested using the two-tailed χ2-test, or with 
Fisher’s exact test, if the table had any cells with an expected frequency of less than 
five. Odds ratios for impaired distance and near VA, adjusting for age and gender, 
were calculated using logistic regression. The 95% confidence intervals for 
prevalences and proportions were calculated using the logit transformation to ensure 
that the confidence limits were between 0% and 100%. 
 
4.4.2 Study II 
The prevalences of self-reported and test-based impairments in mobility were 
calculated as percentages among participants with or without psychotic disorders 
and handgrip strength was compared among these groups. Differences between 
categorical variables were tested using the two-tailed χ2-test, or with Fisher’s exact 
test, if the table had any cells with an expected frequency of less than five, and 
between continuous variables by using the t-test. Odds ratios for impaired mobility, 
adjusting for age and gender, were calculated using logistic regression. The 95% 
confidence intervals for prevalences and proportions were calculated using the logit 
transformation to ensure that the confidence limits were between 0% and 100%. 
 
Logistic regression was used to further explore the odds of having mobility 
limitations in different diagnostic groups. Two types of limitations were assessed, 
based on their functional significance in everyday life: difficulties in stair climbing 
and in walking. Walking limitation was defined as walking speed less than 1.2 m per 
second, if walking speed was measured, or self-reported difficulty in walking 500 
metres if the walking speed test had not been carried out. Besides psychiatric 
diagnoses, we included the following explanatory variables: age, gender, smoking, 
obesity (BMI ≥ 30 kg/m2), type 2 diabetes, coronary heart disease, heart failure, 
knee osteoarthritis and hip osteoarthritis. These variables were associated with 
mobility limitations in the Finnish general population (Sainio et al., 2007). Because 
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some of these conditions were too rare in persons with non-affective psychosis to be 
analysed separately, one variable for having either type 2 diabetes, CHD, heart 
failure, knee or hip osteoarthritis was formed. Heart failure and osteoarthritis were 
self-reported, while type 2 diabetes and CHD diagnoses were made using 
information from laboratory tests, ECG, symptoms, medication and registers 
(Kattainen et al., 2006, Suvisaari et al., 2008).  
 
Among persons with psychotic disorder, we investigated whether the lifetime 
severity of positive, negative, disorganised and depressive symptoms predicted 
mobility limitations after adjusting for variables related to mobility in the general 
population.  
 
4.4.3 Study III 
The prevalences of self-reported impairments in everyday functioning among 
participants with or without psychotic disorder were calculated in percentages. 
Differences between categorical variables were tested using the two-tailed χ2-test 
and between continuous variables by using the t-test. Comparisons of self-reported 
and objective memory deficits were calculated using the t-test. Odds ratios for 
impaired mobility, adjusting for age and gender, were calculated using logistic 
regression. The 95% confidence intervals for prevalences and proportions were 
calculated using the logit transformation to ensure that the confidence limits were 
between 0% and 100%.  
 
To estimate the effect of the psychotic disorder on limitations in everyday 
functioning, when taking the other variables affecting it into account, we made two 
sets of logistic regression models predicting ADL, IADL and social functioning. The 
first models controlled for age and gender and the second added obesity, chronic 
conditions (type 2 diabetes, CHD, heart failure, knee osteoarthritis and hip 
osteoarthritis), verbal fluency and memory, expressive and receptive speech, 
education, distance vision and near vision. Difficulties in ADL, IADL or social 
functioning were coded as present if the participant had difficulties in at least one of 
the items in that domain.  
 
Another logistic regression was used to further explore the odds of having 
difficulties in everyday functioning within the non-affective psychosis group. We 
included the following explanatory variables: age, gender, obesity, chronic 
conditions, verbal memory, positive, negative, disorganised and depressive 
symptoms, and distance and near vision. In the model of social functioning we 
added expressive speech.  
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4.4.4 Study IV 
To estimate the association between psychotic disorders and HRQoL or QoL, 
separate multiple regression models were made using each of the instruments (15D, 
EQ-5D, QoL) as dependent variables. To estimate the effects of covariates, four sets 
of regression models were created in a stepwise manner: the first models controlled 
for age and gender, the second added education, income and marital status, the third 
25 somatic conditions and the fourth Beck’s Depression Index (BDI). The covariates 
were entered as categorical variables except for BDI, which was entered as 
continuous. Linear regression for survey data was used to analyse subjective QoL. 
As the HRQoL measures have a ceiling effect (55.4% of respondents scored full 
health on the EQ-5D and 17.3% on the 15D) a Tobit model was used to account for 
this censoring (Austin et al., 2000, Tobin, 1958). To investigate which dimensions 
of HRQoL were affected by schizophrenia, schizoaffective disorder and bipolar I 
disorder, 15D profiles using linear regression were created to adjust the losses on 
each 15D dimension for age and gender. As the 15D preference-based scoring 
system scales all dimensions between 0 and 1, the losses are comparable. Spearman 
rank-order correlations as partial correlations adjusting for age and gender, were 
used to investigate the correlations between QoL/HRQoL ratings and clinician-rated 
symptom severity and outcome.  
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5 Results 
5.1 Characteristics of the study sample 
 
The mean age in all the diagnostic groups was over 50 years. Persons with ONAP 
were older and more often female than in the other groups. Participants with 
schizophrenia had the most severe lifetime positive, negative and disorganised 
symptoms, while participants with affective psychoses had the most severe 
depressive symptoms. The mean duration of illness was more than 17 years in 
schizophrenia and more than 22 years in ONAP, while it was 12 years in the case of 
persons with affective psychotic disorder. Most of the persons with schizophrenia 
had a chronic course of illness while in other diagnosis groups the course of illness 
was less chronic. Almost all participants had used antipsychotic medication at some 
point of their illness, and most of the persons with schizophrenia, almost a half of 
those with ONAP and a third of those with affective psychotic disorder had current 
antipsychotic medication.  
 
More than half of persons with schizophrenia or ONAP had only basic education, 
while almost half of the persons with affective psychotic disorder had high 
education. Persons with schizophrenia and ONAP had less than 10 years of 
education, while persons with affective psychosis had almost 11 years, as much as 
the remaining study population. 
 
Smoking was more common among persons with schizophrenia, while in other 
diagnosis groups it was as common as in the remaining study population. There 
were more obese people (BMI>30 kg/m2) in the schizophrenia and ONAP groups 
than in the remaining study population. Type 2 diabetes was more common in 
persons with schizophrenia than in the remaining study population, while other 
chronic conditions (CHD, heart failure and osteoarthritis of the hip or knee) were not. 
The higher mean age of those with ONAP is probably one explanation for the higher 
prevalence of heart failure and osteoarthritis of the hip or knee. The characteristics 
of the participants of this study are shown in Table 6. 
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Table 6. Characteristics of the study sample by diagnostic groups (means and percentages). 
 Schizophrenia Other non-affective 
psychotic disorder 
Affective 
psychotic disorder 
No psychotic disorder 
Number of participants 61 79 45 6927 
 Mean SD Mean SD Mean SD Mean SD 
Age  53.4 13.5 57.9 15.8 53.9 16.4 52.9 16.2 
Lifetime severity of symptoms  
Negative (range 0-20) 
Positive (range 1-10) 
Disorganised (range 1-9) 
Depressive (range 1-5) 
 
10.7 
6.8 
5.4 
2.1 
 
3.9 
1.4 
2.0 
0.8 
 
6.2 
5.4 
3.5 
2.5 
 
3.6 
1.5 
1.8 
1.2 
 
4.9 
4.2 
0 
3.6 
 
2.7 
1.4 
0 
0.9 
 
 
 
Duration of illness in years 17.5 11.3 22.2 10.0 12.0 11.2   
 % 95% CI % 95% CI % 95% CI % 95% CI 
Men   45.7  35.2  58.5  47.6  
Course of illness  
Single episode, full recovery 
Multiple episodes, full recovery 
Multiple episodes, partial recovery 
Chronic with exacerbations 
Chronic without exacerbations 
 
0 
3.5 
26.6 
66.2 
3.7 
 
 
0 
0.8-13.1 
16.9-39.3 
52.8-77.4 
1.0-13.2 
 
18.1 
20.2 
39.4 
22.3 
0 
 
10.5-29.2 
11.8-32.5 
27.5-52.7 
13.1-35.3 
0 
 
19.8 
48.4 
29.2 
2.7 
0 
 
10.2-34.8 
33.7-63.3 
16.7-46.0 
0.3-16.5 
0 
  
 
 
 
 
 
 
Current use of 
Antipsychotics 
Antidepressants 
Mood stabilisers 
 
Lifetime use of antipsychotics 
 
68.3 
21.1 
5.3 
 
98.3 
 
56.2-78.4 
12.9-32.5 
1.8-14.5 
 
89.4-99.8 
 
45.2 
32.9 
6.7 
 
87.3 
 
35.1-55.7 
22.9-44.7 
2.8-15.3 
 
78.7-92.8 
 
32.0 
33.6 
10.7 
 
97.5 
 
18.8-48.8 
21.5-48.2 
4.6-22.8 
 
84.3-99.7 
 
1.3 
5.1 
1.1 
 
1.0-1.5 
4.6-5.6 
0.9-1.3 
 
 
Education  
High 
Secondary 
Basic 
Years (mean) 
 
19.9 
24.7 
55.5 
9.6 
 
11.6-31.9 
15.3-37.3 
43.8-66.5 
3.6 
 
20.9 
23.0 
54.1 
9.7 
 
13.3.-31.2 
15.8-37.3 
43.1-64.7 
4.5 
 
42.9 
16.4 
40.7 
10.8 
 
29.3-57.6 
8.5-29.4 
26.6-56.6 
4.2 
 
40.5 
32.1 
27.4 
11.0 
 
39.1-42.0 
30.9-33.3 
26.2-28.6 
4.2 
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Table 6. (Continued)         
Smoking  
Current smoker 
Ex-smoker 
Do not smoke 
 
43.7 
17.0 
39.2 
 
31.4-56.9 
9.5-28.7 
27.6-52.2 
 
28.4 
21.1 
50.5 
 
19.7-38.9 
13.2-32.0 
40.0-61.0 
 
29.4 
29.5 
41.1 
 
17.5-45.0 
17.8-44.6 
28.3-55.2 
 
27.2 
22.1 
50.8 
 
26.1-28.2 
21.2-23.0 
49.6-52.9 
BMI kg/m2  
<20 
20-25 
25-30 
30-35 
>35 
 
3.7 
30.8 
30.6 
19.2 
15.8 
 
0.9-13.6 
20.4-43.5 
20.5-43.0 
10.7-32.0 
8.7-27.0 
 
5.4 
23.2 
28.9 
21.3 
21.2 
 
2.1-13.4 
15.7-32.9 
19.6-40.4 
13.1-32.7 
13.3-32.0 
 
0 
27.5 
45.6 
24.5 
2.5 
 
0 
16.5-42.1 
31.8-60.0 
13.5-40.2 
0.35-15.7 
 
3.7 
34.0 
40.4 
16.8 
5.1 
 
3.3.-4.2 
32.8-35.2 
39.2-41.6 
15.9-17.7 
4.6-5.7 
Chronic condition  
Diabetes mellitus type 2 
Coronary heart disease  
Heart failure 
Osteoarthritis of the hip/knee 
 
22.1 
13.0 
5.8 
13.9 
 
13.2-34.7 
6.8-23.4 
2.1-14.7 
7.1-25.7 
 
15.6 
11.3 
11.5 
17.1 
 
8.9-26.1 
6.2-19.7 
5.8-21.6 
10.1-27.5 
 
3.4 
5.0 
0 
1.2 
 
0.8-13.5 
1.5-15.8 
0 
0.2-8.0 
 
6.1 
10.8 
4.5 
12.6 
 
5.5-6.8 
10.0-11.7 
4.0-5.0 
11.8-13.5 
Distance vision  
≥0.8+ 
0.63-0.5 
0.4-0.25 
≤0.25 
 
70.1 
18.9 
9.2 
1.8 
 
56.7-80.7 
10.4-31.7 
3.9-20.2 
0.3-11.5 
 
78.1 
13.1 
6.9 
1.9 
 
67.2-86.1 
7.0-23.2 
2.8-16.0 
0.5-7.2 
 
86.0 
12.8 
1.2 
0 
 
72.0-93.7 
5.5-26.9 
0.2-8.5 
0 
 
87.6 
8.4 
2.2 
1.5 
 
86.8-88.4 
7.8-9.1 
2.0-2.7 
1.2-1.9 
Near vision  
≥0.8+ 
0.63-0.5 
0.4-0.25 
≤0.25 
 
50.5 
35.5 
12.0 
2.0 
 
36.4-64.5 
23.8-49.3 
5.4-24.4 
0.3-12.6 
 
77.3 
17.1 
0 
5.6 
 
66.7-85.2 
10.0-27.7 
0 
2.1-14.3 
 
75.4 
23.0 
1.6 
0 
 
57.9-87.3 
11.6-40.6 
0.2-10.5 
0 
 
82.1 
13.7 
2.4 
1.8 
 
81.1-83.1 
12.9-14.7 
2.0-2.7 
1.5-2.1 
BMI=body mass index 
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5.2 Visual impairment of persons with psychotic disorder 
(Study I) 
 
Persons with schizophrenia wearing glasses in the VA test had good distance VA 
(≥0.8) (81%, 95%CI 59.8-92.4) almost as often as those in the remaining study 
population (89.7%, 95%CI 88.7-90.6). VA for near decreased significantly. 58.3% 
(95%CI 40.0-74.6) had good VA for near, compared to 83.7% (95%CI 82.5-84.8) in 
the remaining study population. Among participants who did not wear glasses in the 
examination, 63.6% (95%CI 46.5-77.8) of those with schizophrenia had good VA 
for distance and only 40.1% (95%CI 22.0-61.3) had good VA for near, when the 
corresponding prevalences in the remaining study population were 86.0% (95%CI 
84.7-87.1) and 83.5% (95%CI 81.8-85.1). The same pattern was observed in the 
ONAP group, but only in distance VA. Persons with affective psychosis did not 
differ from the remaining study population in terms of distance and near VA (Table 
2 in original Study I).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Age- and gender-adjusted odds ratios of having visual impairment 
(VA<0.5)  
 
After adjusting for age and gender, schizophrenia was associated with five-fold odds 
of having visual impairment (VA<0.5) for distance (OR 5.04, 95%CI 1.89-13.48, 
P<0.001) and six-fold odds of having visual impairment for near vision (OR 6.22, 
95%CI 2.61-14.82, P<0.001). The odds of having visual impairment were not 
increased in the ONAP and affective psychosis groups (Figure 3). 
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Participants with schizophrenia and ONAP, but not with affective psychosis, 
reported more difficulties in both distance and near vision than the remaining study 
population. Although those with schizophrenia had reported problems, they tended 
to report fewer problems than they actually had according to VA measurement.  
 
Only 43.9% of persons with schizophrenia, compared with 69.7% in the remaining 
study population (χ2=13.79, df 1, P=0.0002), had had their vision examined during 
the five years before the Health 2000 examination. Persons with ONAP had also had 
their vision examined significantly less often (59.0%) than persons in the remaining 
study population (χ2=3.87, df 1, P=0.049), whereas those with affective psychosis 
had attended vision examinations almost as often as the remaining study population 
(63.9%). 
 
The diagnostic groups were combined when studying the impact of antipsychotic 
medication to have a larger sample size. After adjusting for age and gender, use of 
any antipsychotic medication was not associated with odds of having visual 
impairment (VA<0.5) for distance (OR 0.78, 95%CI 0.26-2.31, P=0.66) or for near 
vision (OR 2.53, 95% CI 0.84-7.59, P=0.097). In contrast, phenothiazine use was 
associated with significantly impaired near VA (OR 5.07, 95%CI 1.13-22.81, 
P=0.034), but not with distance VA (OR 2.55, 95%CI 0.46-14.21, P=0.284). 
 
An association between diabetes and reduced VA in persons with psychotic disorder 
was not found.  
 
5.3 Mobility limitations of persons with psychotic disorder 
(Study II) 
 
Persons with schizophrenia or ONAP reported many more limitations in mobility 
than those with affective psychosis, who did not differ significantly from the 
remaining study population. Impairments were already common in participants 
under 55 years in both diagnosis groups and in all functions of mobility. For 
example, people with schizophrenia had significantly increased odds of having 
difficulties in walking 500 metres (OR 7.28, 95%CI 2.7-19.37) and climbing one 
flight of stairs (OR 8.16, 95%CI 2.85-23.33), already under 55 years of age. In the 
ONAP group the odds were somewhat smaller, but still significantly increased. The 
handgrip strength of persons with schizophrenia and older persons with ONAP was 
notably weaker than in the other participants, but persons with affective psychosis 
did not differ from the remaining study population (Table 2 in original Study II).  
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Age- and gender-adjusted self-reported limitations in walking 500 metres and test-
based limitations in walking (walking speed <1.2 m/s) are shown in Figure 4. 
Schizophrenia was associated with more than five-fold odds (OR 5.28, 95%CI 2.42-
11.53) and ONAP with more than two-fold odds (OR 2.29, 95%CI 1.17-4.47) of 
having self-reported limitations in walking. ONAP was associated statistically 
significantly (OR 3.55, 95%CI 1.69-7.45) with measured limitations in walking, 
while schizophrenia was just under statistical significance (OR 2.64, 95%CI 0.96-
7.26). The affective psychosis group did not differ significantly from the remaining 
study population (Table 3 in original Study II). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Age- and gender-adjusted limitations in walking 
 
 
Figure 5 presents the self-reported limitations in climbing one flight of stairs and 
test-based limitations in walking two flights of stairs. Schizophrenia was statistically 
significantly associated with both self-reported (OR 6.06, 95%CI 3.05-12.02) and 
measured (OR 4.09, 95%CI 1.39-11.99) limitations in stair climbing, while ONAP 
was statistically significantly associated with self-reported limitations (OR 3.59, 
95%CI 1.91-6.78). Affective psychotic disorder was not associated with limitations 
in stair climbing (Table 3 in original Study II). 
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Figure 5. Age- and gender-adjusted limitations in stair climbing. 
 
 
After adjusting for factors other than age and gender related to mobility limitations 
in the general population, like smoking, obesity and chronic conditions, 
schizophrenia was still independently associated with significantly increased odds of 
having self-reported limitations in walking (OR 3.11, 95%CI 1.22-7.96) and 
climbing stairs (OR 4.65, 95%CI 2.15-10.03). Participants with ONAP had test-
based difficulties in walking (OR 2.88, 95%CI 1.34-6.21) and self-reported 
difficulties in climbing stairs (OR 3.45 95%CI 1.76-6.74) (Table 3 in original Study 
II).  
 
Next, we investigated whether the severity of psychiatric symptoms in persons with 
non-affective psychosis was associated with mobility limitations, after adjusting for 
those variables that have been found to be associated with mobility limitations in the 
total study population. Negative symptoms (OR 1.24, P=0.0475) and age (OR 1.21, 
P<0.0001) were independently associated with difficulty in walking, when the 
explanatory variables were lifetime severity of negative, positive, disorganised and 
depressive symptoms, smoking, obesity, type 2 diabetes, knee osteoarthritis, hip 
osteoarthritis, CHD and heart failure. 
 
The difference in the amount of exercise between the diagnostic groups and those 
without psychotic disorder was seen only among persons aged 55 or older. Those 
with schizophrenia (53.1%, χ2=4.32, df=1, P=0.0377) and affective psychosis 
(63.2%, χ2=4.50, df=1, P=0.0340) reported more often than persons without 
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psychotic disorder (27.8%) that they do not exercise or strain themselves physically 
in their leisure time.  
 
5.4 Everyday functioning of persons with psychotic disorder 
(Study III) 
 
Self-reported limitations in activities of daily living (ADL), instrumental activities 
of daily living (IADL) and social functioning were most common in persons with 
schizophrenia, followed by persons with ONAP. Persons with schizophrenia 
reported the largest limitations in IADL and social functioning. For example, 36.1% 
of persons with schizophrenia reported difficulties in cooking (χ2=16.36, df=1, 
P=0.0001), 45.2% in heavy cleaning (χ2=11.36, df=1, P=0.0008), 28.8% in 
communicating with strangers (χ2= 10.81, df=1, P=0.0010) and 23.9% in dealing 
with the authorities and financial institutions (χ2=5.90, df=1, P=0.0152). Participants 
with ONAP reported almost as many difficulties in IADL as those with 
schizophrenia, but in social functioning they reported fewer difficulties, although 
significantly more than the remaining study population. Participants with affective 
disorder did not report significantly more limitations than the remaining study 
population (Table 2 in original Study III).  
 
Figure 6 presents the age- and gender-adjusted limitations of ADL, IADL and social 
functioning as combined domains. Schizophrenia and ONAP were statistically 
significantly associated with limitations in all domains. Persons with schizophrenia 
had almost 10-fold odds of having limitations in IADL (OR 9.85, 95%CI 4.85-20.02) 
and more than 12-fold odds of having limitations in social functioning (OR 12.24, 
95%CI 5.55-27.03). Persons with ONAP had somewhat smaller odds of having 
limitations in these domains (OR 3.74, 95%CI 2.15-6.50 and OR 4.88, 95%CI 2.67-
8.93, respectively). Affective psychotic disorder was not associated with limitations 
in either ADL, IADL or social functioning (Table 4 in original Study III). 
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Figure 6. Age- and gender-adjusted limitations in ADL, IADL and social functioning. 
 
 
After adjusting for other factors that may affect functioning, such as age, gender, 
obesity, chronic conditions, verbal memory and fluency, expressive and receptive 
speech, education and vision, schizophrenia and ONAP remained significant 
determinants of impaired IADL and social functioning (Table 3 in original Study III).  
 
In the logistic regression model, which analysed factors associated with difficulties 
in everyday functioning in the group of non-affective psychosis, age and depression 
were independently associated with difficulties in ADL, while age, negative 
symptoms, depression and verbal memory were associated with impaired IADL. 
Depression, distance vision and expressive speech problems were associated with 
difficulties in social functioning (Table 5 in original Study III). 
 
After adjusting for age and gender, persons with schizophrenia performed more than 
five times weaker than those without psychotic disorder in verbal fluency (Beta -
5.60, 95%CI -7.26, -3.94) and statistically significantly also in immediate and 
delayed verbal memory (Beta -0.96, 95%CI -1.39,-0.54 and Beta -1.34, 95%CI -
1.81,-0.88). ONAP was also significantly associated with lower performance in both 
verbal fluency and verbal memory. In contrast, only delayed memory was weaker in 
persons with affective psychotic disorder compared to those without psychotic 
disorder. Self-reported memory problems were not more common among persons 
with psychotic disorder, but those with schizophrenia reported more memory-related 
problems in their everyday life than those without psychotic disorder (OR 3.32, 
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95%CI 1.50-7.32), while other diagnostic groups did not (Table 3 in original Study 
III).  
 
Persons with schizophrenia performed poorly in the memory test regardless of 
whether they reported subjective memory problems or not (means 4.09 and 4.35 
words, t-test=0.58, P=0.5672). In the ONAP group persons who reported subjective 
memory problems also performed worse in the memory tests (means 3.52 and 5.15 
words, t-test=4.02, P=0.0002). In the affective psychosis group, persons performed 
well in the memory test regardless of whether they reported subjective memory 
problems or not (means 4.57 and 5.08 words, t-test=0.86, P=0.3977). 
 
Persons with schizophrenia and ONAP had received assistance in their everyday 
activities more often (39.0%, χ2=15.33, df=1, P=0.0001 and 24.6%, χ2=7.20, df=1, 
P=0.0074, respectively) than persons without psychotic disorder (9.5%). When we 
compared those subjects with schizophrenia and ONAP who had ADL limitations, 
80.4% (χ²=1.48, df=1, P=0.2231) and 85.0% (χ²=6.56, df=1, P=0.0105) received 
assistance compared to 57.0% of those without psychotic disorder. In IADL 
limitations the proportions were 56.4% (χ²=4.13, df=1, P=0.0421) and 47.7% 
(χ²=1.23, df=1, P=0.2682) compared to 38.8% of those without psychotic disorder, 
and in limitations with social functioning they were 68.5% (χ²=0.28, df=1, P=0.5951) 
and 59.8% (χ²=0.19, df=1, P=0.6636) compared to 64.0% of those without psychotic 
disorder.  
 
Interviewers estimated that persons with schizophrenia and ONAP needed more help 
than the remaining study population. About 31.2% (χ²=9.03, df=1, P=0.0027) of 
those with schizophrenia and 8.5% (χ²=5.54, df=1, P=0.019) of those with ONAP 
would have needed help according to the interviewer but were not provided with it, 
compared with 3.8% of the remaining study population. 
 
5.5 Quality of life of persons with psychotic disorder (Study IV) 
 
Participants with a non-affective psychotic disorder other than schizophrenia had the 
lowest unadjusted HRQoL scores; the mean 15D score was 0.08 and the EQ-5D 
score 0.17 points lower than the mean of the population without psychosis. For 
schizophrenia these differences were 0.07 and 0.12, respectively (Table 1 in original 
Study IV). Adjusted with age and gender, schizophrenia, ONAP and affective 
psychotic disorder were all associated with decreases of 0.05-0.06 points on the 15D. 
On the EQ-5D the diagnoses had bigger differences: the decreases were 0.12 for 
schizophrenia, 0.11 for ONAP and 0.06 for affective psychotic disorder (Table 2 in 
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original Study IV). The HRQoL profiles of 15D are presented in Figure 7 as age- 
and gender-adjusted decreases from population averages.  
 
Considering individual disorders, persons with schizoaffective disorder had the 
largest age- and gender-adjusted losses of HRQoL: -0.09 on the 15D and -0.15 on 
the EQ-5D. EQ-5D did not find any HRQoL losses for delusional or bipolar I 
disorder, although all disorders were associated with statistically significant 
decreases on the 15D (Table 3 in original Study IV).  
 
The ONAP group had the lowest unadjusted subjective QoL scores, 1.6 points below 
the population without psychosis and also had the largest reductions of QoL in all 
the regression models. Persons with schizophrenia had statistically significant 
reductions of subjective QoL only when adjusted for age and gender. The affective 
psychosis group was between the other groups. Of individual disorders, persons with 
schizoaffective disorder had the worst subjective QoL, whereas those with bipolar I 
disorder did not have a statistically significant reduction of QoL (Table 3 in original 
Study IV). 
 
Current depression had a significant effect on HRQoL. Adding BDI into the models 
diminished the impact of disorders in EQ-5D and only schizophrenia and 
schizoaffective disorder were associated with statistically significant reductions of 
the 15D after controlling for the BDI. The situation was similar in the case of 
subjective QoL, except that for schizophrenia socioeconomic variables explained 
most of the reduction of QoL and delusional disorder was the only disorder still 
statistically significantly reduced after controlling for the BDI. 
 
The Spearman correlations were calculated between QoL/HRQoL and clinician-
rated positive, negative, disorganisation and depressive symptoms, course and 
outcome. For schizophrenia correlations were not statistically significant except 
between depressive symptoms and QoL. For schizoaffective disorder, there were 
large (<-0.5) negative correlations between negative symptoms, course, outcome and 
QoL/HRQoL. For delusional disorders none of the correlations were statistically 
significant. For bipolar I disorder, there were large negative correlations between 
depressive symptoms and HRQoL measures and moderate correlations (-0.3 to -0.5) 
between depression and QoL. Correlations were positive but not statistically 
significant between lifetime mania ratings and QoL/HRQoL scores. Negative 
correlations between course, outcome and QoL/HRQoL ratings were mostly 
moderate or large. For MDD with psychotic features, correlations were negative and 
large for negative symptoms and the EQ-5D and QoL and correlations between 
course, outcome and QoL/HRQoL ratings were negative and mostly moderate or 
large. 
 THL 2011 – Research 60 73 
Functional Limitations and 
Quality of Life in Schizophrenia 
and Other Psychotic Disorders 
 
 
(a) Age- and gender-adjusted losses in schizophrenia 
 
(b) Age- and gender-adjusted losses in schizoaffective disorder 
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(c) Age- and gender-adjusted losses in bipolar I disorder 
 
 
 
 
Figure 7. Age- and gender-adjusted losses on different health-related quality of life 
dimensions (15D) with 95% confidence intervals in persons with (a) schizophrenia, 
(b) schizoaffective disorder and (c) bipolar I disorder compared to the remaining 
study population (0-level). 
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15D dimensions are: Move=mobility, See=vision, Hear=hearing, Breath=breathing, Sleep=sleeping, 
Eat=eating, Speech=speech, Elim=elimination, Uact=usual activities, Mental=mental function, 
Discc=discomfort and symptoms, Depr=depression, Distr=distress, Vital=vitality, Sex=sexual activity 
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6 Discussion 
6.1 Principal findings 
 
In this general population study, it was found that persons with schizophrenia often 
had impairments in their habitual distance and near vision. In contrast, those with 
ONAP or affective psychotic disorder did not have increased odds of impaired VA 
after adjusting for age and gender. Participants with schizophrenia reported fewer 
problems in reading newspaper print and television subtitles than they actually had 
according to the VA measurements. Persons with psychotic disorder who were 
currently using antipsychotics did not have more impaired VA than those who did 
not use antipsychotics, but phenothiazine use was associated with impaired near 
vision. Participants with schizophrenia or ONAP did not report more 
ophthalmologic diseases than the remaining study population. Existence of 
undiagnosed diseases is possible however, since persons with schizophrenia had had 
their vision examined during the past five years much less often than the rest of the 
study population. Although diabetes has a large impact on vision in the general 
population (Buch et al., 2004), this was not found to be the case in this study in 
participants with psychotic disorders. The reason for this may be the relatively small 
number of participants with psychotic disorder with comorbid type 2 diabetes and 
high prevalence of impaired VA in the schizophrenia group that may have masked 
the effect of diabetes.  
 
According to the results of this study, persons with schizophrenia and ONAP have a 
considerably higher risk of mobility limitations than those without psychotic 
disorder. In the general population, difficulties in mobility are rare under the age of 
55, but they are quite common among participants with schizophrenia in particular. 
They reported difficulties in all levels of mobility, even in walking short distances 
and climbing stairs. For example, problems in walking 100 metres while carrying 
five kilograms or climbing one flight of stairs are probably associated with some 
difficulties in everyday functioning due to poor physical condition. Handgrip 
strength was the only objective measure of physical condition in persons aged 30-54 
years. In persons with schizophrenia, it was almost one standard deviation weaker 
than in the remaining study population, even in participants under 55 years. Such 
weak muscle strength is likely to have an impact on functional capacity. Persons 
with affective psychotic disorder did not differ from the remaining study population 
in mobility. Negative symptoms and age were independently associated with 
difficulty in walking in participants with schizophrenia and ONAP. 
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In everyday functioning, persons with schizophrenia and ONAP had considerable 
impairment across several measures. Participants with schizophrenia in particular 
had a multi-fold risk of difficulties in IADL and social functioning, but they had 
difficulties in ADL, too, in contrast to those with ONAP. The results of the cognitive 
tests showed the same pattern: persons with schizophrenia and ONAP performed 
significantly worse than those without psychotic disorder in both verbal fluency and 
verbal memory. Those with schizophrenia also reported significantly more problems 
in everyday life because of poor memory than the other groups. Participants with 
affective psychotic disorder did not differ from the remaining study sample, apart 
from cooking in IADL, taking care of matters together with other people and 
communicating with strangers in social functioning and in delayed verbal memory 
in cognitive tests. Thus, the functional capacity of persons with a lifetime history of 
affective psychosis is relatively well-preserved, whereas persons with schizophrenia 
and ONAP have impairments in most areas of everyday functioning. 
 
Participants with schizophrenia and ONAP had difficulties in understanding speech 
and speaking understandably. These kinds of difficulties hinder relationships with 
other people, as was seen in this study, where problems in speaking understandably 
were independently associated with social functioning. Other factors associated with 
difficulties in social functioning were depression and distance vision. Age and 
depression were independently associated with difficulties in ADL, while age, 
negative symptoms, depression and verbal memory were associated with difficulties 
in IADL. Interviewers who met the participants in their homes were able to evaluate 
the need for assistance based on living conditions and the participant’s behaviour at 
home. Those persons with schizophrenia and ONAP who had self-reported 
limitations had received assistance in their everyday activities more often than those 
without psychotic disorder, but the help they received was not sufficient enough.  
 
Schizoaffective disorder was associated with the lowest HRQoL in all measures 
used, followed by schizophrenia and bipolar I disorder. Schizophrenia and bipolar 
disorder were associated with a relatively larger loss of HRQoL than subjective QoL, 
but the opposite was true for delusional disorder and MDD with psychotic features. 
The findings suggest that the subjective suffering reported by people with 
schizophrenia is smaller than the objectively measured functional disability related 
to the disorder. Current depression, measured with the Beck Depression Inventory, 
explained most of the loss of HRQoL and QoL found, which questions the utility of 
utility-based HRQoL measurements as sole outcome measures in psychotic 
disorders and also emphasises the importance of treating depressive symptoms in 
psychotic disorders. 
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6.2 Comparison to previous studies 
6.2.1 Visual acuity 
In this study, VA was measured with the participant’s own glasses, while with two 
exceptions (Punukollu and Phelan, 2006, Ungvari et al., 2002) previous studies have 
measured VA with the best optic corrections. All recent studies have found a high 
prevalence of VA problems in people with schizophrenia (Smith et al., 1997, 
Ungvari et al., 2002). Although participants with schizophrenia did not report more 
ophthalmologic diseases, they may have had more undiagnosed diseases due to lack 
of regular examinations. A previous study found ocular abnormalities in 83% of 
Australian inpatients (Smith et al., 1997). Some antipsychotic drugs, particularly 
phenothiazines and quetiapine, may be associated with higher risk of developing 
ophthalmologic diseases (Isaac et al., 1991, Marder et al., 2004, Punukollu and 
Phelan, 2006, Ruigomez et al., 2000) and antipsychotic medication may also 
temporarily cause blurred vision as an anticholinergic side effect (Lieberman, 2004). 
Thus, the results are consistent with previous research and suggest: (1) visual 
impairment is common in persons with schizophrenia, (2) this may be caused by 
inadequately corrected refraction errors or possible undiagnosed ophthalmologic 
diseases, and (3) anticholinergic side effects of antipsychotic medication may cause 
impairment in near vision. 
 
6.2.2 Mobility limitations 
Mobility of people with psychotic disorder has been scarcely studied. Most studies 
have concerned the effectiveness of physical activity and exercise programmes for 
people with psychotic disorder (Daumit et al., 2005, Osborn et al., 2007, Roick et al., 
2007). In these studies exercise has been a way to treat the obesity and glucose 
dysregulation often associated with psychotic disorders, but the problems in 
mobility in itself have not been studied. In this study the prevalence of physical 
inactivity was high, as in most previous studies (Daumit et al., 2005, Osborn et al., 
2007, Roick et al., 2007). The muscle strength of persons with schizophrenia was 
weaker than in the remaining study population and this is consistent with possibly 
the only previous study about the subject (Callison et al., 1971). Mobility is a 
neglected area of functioning research in psychiatry, although it is an important 
factor in everyday functioning. In a recent longitudinal study of elderly persons, 
geriatric impairments – e.g. muscle strength, physical capacity, vision and cognition 
– were more strongly associated with the onset on disability in ADL than chronic 
diseases and nearly as strongly associated with the onset of disability in mobility 
(Chaudhry et al., 2010). 
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6.2.3 Everyday functioning 
Everyday functioning of people with schizophrenia and other psychotic disorders 
has been studied widely. In most studies the impairments in activities of daily living 
have been explained by cognition and symptoms. An American research group 
(Bowie et al., 2010, Bowie et al., 2008, Bowie et al., 2006) found in their analyses 
that neuropsychological performance has both a direct and an indirect effect on 
everyday functioning. Depressive symptoms have a direct effect on interpersonal 
skills and work skills and negative symptoms have a direct effect on interpersonal 
skills but a mediated effect through neuropsychological functioning on work skills 
and community activities. A study from the same research group by Leifker et al. 
(2009) found that positive symptoms of hallucinatory behaviour and suspiciousness 
also predicted real-world residential outcomes.   
 
The present study replicated previous findings regarding the relationship between 
everyday functioning and negative and depressive symptoms (Bowie et al., 2006, 
Green, 1996, Jin et al., 2001, Patterson et al., 1998, Simon et al., 2007). Depression 
was independently associated with difficulties in ADL, IADL and social functioning 
and negative symptoms were associated only with IADL. This study showed that 
reduced vision and problems in speaking understandably were also associated with 
social functioning. The findings related to reduced vision are particularly 
noteworthy, since vision might have been easily corrected with proper glasses. 
However, it may also be that poor functioning in itself is the reason for the 
incapability to acquire glasses.  
 
As was the case in the present study, the needs of patients with severe mental illness 
are often unmet. Sometimes the health care personnel do not succeed in recognising 
the needs of the patients (Phelan et al., 1995). A Nordic multicentre study found that 
18.7% of patients with schizophrenia have serious unmet needs in their daytime 
activities (Middelboe et al., 2001). Another study from the same sample found that 
health care personnel and patients agree most on the needs concerning functional 
skills (Korkeila et al., 2005).  
 
6.2.4 Cognitive functioning 
In this study it was possible to use only simple cognitive measures for cognitive 
assessment, in contrast to many other studies, in which cognition was measured with 
a wide range of neuropsychological tests. Both verbal fluency and verbal memory 
were impaired in persons with non-affective psychotic disorder, and verbal memory 
was independently associated with difficulties in IADL. The results of this study 
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were in concordance with previous studies, since verbal memory and fluency have 
often been found to be impaired in persons with psychotic disorder (Bowie et al., 
2008, Godbout et al., 2007, Heinrichs and Zakzanis, 1998, Mesholam-Gately et al., 
2009). In a recent review by Bora et al. (2009) individuals with affective psychosis 
performed slightly, but not statistically significantly better than those with 
schizophrenia in verbal memory. In our study only delayed verbal memory was 
poorer in persons with affective psychotic disorder than in the remaining study 
population.   
 
6.2.5 Quality of life 
Most previous studies measuring quality of life in persons with psychotic disorder 
have been clinical studies, where participants are currently in treatment (Knapp et al., 
2008, Prieto et al., 2004). Compared to these studies, the HRQoL values were better 
in this population-based study.  
 
The results of this study are in concordance with the previous literature in 
suggesting that, on average, schizoaffective disorder is associated with more severe 
impairment in HRQoL than schizophrenia (Narvaez et al., 2008). In previous studies, 
current depressive (Narvaez et al., 2008) or depressive/anxiety (Meijer et al., 2009) 
symptoms have had the strongest correlation with QoL, which was found in this 
study too, while correlations with positive, negative or disorganisation symptoms 
were not significant. Depression has also been found to be a strong correlate of life 
dissatisfaction using the Life Satisfaction Score (Allardt, 1973, Koivumaa-
Honkanen et al., 1996, Koivumaa-Honkanen et al., 1999). The effect of depressive 
symptoms on EQ-5D scores was seen also in a study comparing treatment-seeking 
individuals, where those with bipolar disorder had significantly better scores than 
those with schizoaffective disorder (0.77 and 0.67 respectively), and where 
participants with schizoaffective disorder had more depressive symptoms (Kulkarni 
et al., 2008). 
 
According to previous reviews, the HRQoL or QoL of people with bipolar disorder 
are lowered even in the euthymic phase, but clearly less than in the manic phase 
(Namjoshi and Buesching, 2001, Dean et al., 2004, Michalak et al., 2005). In 
reviews comparing schizophrenia and bipolar disorder, most studies show that 
bipolar disorder is either milder than schizophrenia or comparable to it (Dean et al., 
2004, Michalak et al., 2005). A study of community-dwelling patients, using the 
Quality of Well-Being scale or SF-36, did not find statistically significant difference 
between the disorders (Depp et al., 2006). These results are in concordance with the 
results of this study, where participants with schizophrenia had somewhat lower 
scores in EQ-5D and subjective QoL, but only slightly lower scores in 15D. 
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6.3 Methodological discussion 
6.3.1 Strengths 
This study was based on a population-based sample and therefore it was able to 
provide information on the magnitude of the problems of those with psychotic 
disorder in the general population, which has public health relevance. The 
participants in the PIF study are a fairly representative sample of community-
dwelling psychosis patients in Western countries in terms of their occupational 
status and living conditions. The great majority of persons with psychotic disorders 
had received treatment and their occupational outcome was poor. The participation 
rate in the Health 2000 Survey was high, which gives us a better opportunity to 
make generalisations from the results. Also sampling weights were used to adjust for 
sampling variability and errors caused by non-response. The purpose of sampling 
weights is to match the observed data to correspond to the distribution of the target 
population, and therefore our results can be generalised to the target population, i.e. 
the Finnish population. 
 
Psychiatric diagnostics were based not only on the SCID-I interview but also on 
case records from hospital and outpatient treatments, which made the diagnostic 
procedure thorough and reliable. Three experienced clinicians made the final best-
estimate diagnoses and the kappa values between the raters were either good or 
excellent regardless of whether the diagnosis was based on both the SCID interview 
and case records, or case records alone. 
 
The data gathered in the Health 2000 Survey and the PIF Survey are extensive. 
Health 2000 is one of the very few general population surveys that have included 
both a detailed psychiatric assessment and an extensive medical examination. 
Generally the functional capacity of people with schizophrenia and other psychotic 
disorders is not studied with a population-based sample. This kind of research model 
gives us the opportunity to compare functional limitations in people with psychotic 
disorder to the general population.  
 
6.3.2 Limitations 
Because of the relatively small sample of subjects with psychotic disorder, we were 
not able to study all potentially interesting or relevant associations. For example, we 
could not investigate the effect of individual antipsychotic drugs on VA. The 
affective psychosis group in particular was quite small and heterogeneous. The two 
disorders (MDD and BD I) included in the group are quite different by their nature 
and also outcome, and this makes the analysis of the results of this diagnostic group 
rather difficult in some respects. We could compare the severity and symptoms of 
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the non-respondents with those of the respondents, which revealed that people with 
more severe affective psychotic disorder seemed to be somewhat underrepresented. 
Likewise, the ONAP group consisted of different disorders that could not be 
investigated separately because of the small sample size. However, in Study IV we 
also compared the effect of individual psychotic disorders on quality of life, 
realising that the statistical power to detect differences between the groups was 
relatively low. 
 
Because the study is cross-sectional, the problem of causality arises, especially in 
studying mobility limitations. We cannot determine whether inactivity and poor 
health cause impaired mobility or whether weakened mobility causes inactivity and 
poor health. Self-report questions and functional tests did not measure exactly the 
same functions, but both were available for participants aged 55 and older and found 
considerable limitations in mobility in persons with non-affective psychosis.  
 
The HRQoL and QoL results represent the individual disability of participants. 
Therefore the results underestimate the total burden of psychotic disorders because 
mortality and the burden of caregivers are not taken into account. The mean age in 
all diagnostic groups was relatively old, over 50 years. Because psychotic disorders 
usually have an onset before the age of 30, the impact of psychoses may be 
relatively larger in young people when somatic conditions are rare. 
 
Self-report is sometimes considered problematic when studying people with severe 
mental illness (Bowie et al., 2007, Harvey et al., 2007). Poor insight, cognitive 
impairment or psychotic symptoms may distort the way people see their situation. 
Persons with schizophrenia did not report as many problems in vision as the 
measured tests indicated, and they performed poorly in the memory test, regardless 
of whether they reported memory problems or not. However, in Study II it was 
possible to compare self-reported mobility and measured mobility and it was found 
that people with psychotic disorder are capable of reporting about their situation 
quite accurately. A Finnish study of psychiatric patients found that patients with 
schizophrenia self-assessed their work capacity and economic status closer to the 
objective assessment than patients with MDD or anxiety disorder (Koivumaa-
Honkanen et al., 1999). Regardless of its limitations, self-report should remain in 
use as one way to study the functional capacity of people with psychotic disorder. It 
could be particularly useful in clinical care when there is a lack of time or resources 
for more detailed assessments. 
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6.4 Clinical implications  
 
The functional limitations of people with psychotic disorder may have a severe 
impact on their life. The symptoms related to psychotic disorder are often difficult, 
and problems in everyday life, caused by reduced vision, difficulties in walking or 
performing housework, make it even more difficult for these people to cope in 
society and live independently.   
 
It is important to pay more attention to the vision of persons with psychotic disorder 
and especially those with schizophrenia. The visual acuity for both distance and near 
should be examined yearly. This kind of monitoring could be done during an annual 
medical examination. If vision is found to be reduced, the patient should be referred 
to an ophthalmologist or optician and, if needed, patients should receive help in 
acquiring new glasses. An American consensus meeting also recommends annual 
visual examinations for patients with schizophrenia aged over 40 years and every 
second year for patients under 40 years (Marder et al., 2004).  
 
Antipsychotic medication may have negative side effects that lower the quality of 
life. In this study, participants who used any antipsychotics did not have impaired 
VA significantly more often than the remaining study population, but phenothiazine 
use was associated with significantly impaired near VA. Since impairment in 
distance VA was not found, the most likely explanations for reduced VA are either 
blurred near vision due to anticholinergic side effects or uncorrected refractive errors. 
There is no reason to assume that the latter would be more common in subjects 
using phenothiazines than in users of other types of antipsychotics. Clinicians should 
be aware of these potential side effects of antipsychotic medication and consider 
changing to another antipsychotic if the patient has significant vision problems. 
 
Impairments in walking and climbing stairs limit everyday life considerably. 
Mobility limitations should be one of the aspects assessed by health care providers 
when they meet with the patients. The reasons for mobility limitations should also 
be assessed. The reason can include physical illness, poor condition or the 
extrapyramidal side effects of antipsychotic medication. As in many prior studies, 
negative symptoms were associated with limitations in mobility in this study, too. It 
may be that the lack of initiative makes people physically inactive, which in turn 
may cause impaired mobility, after which it is even more difficult to start exercising. 
This kind of ‘vicious circle’ should be stopped in its early phase. If poor condition is 
the reason for mobility limitations, patients should be encouraged to exercise. It may 
be a challenge to spur people with psychotic disorder to become more active, but 
patients may also be more ready to consider lifestyle changes than clinicians realise 
(Archie et al., 2007). 
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Attention should be paid to performance in everyday skills. One part of the patients 
overestimated their functioning in everyday activities. When the patients were not 
aware of the actual need for help, the home interviewers were able to evaluate it. 
Home visits by health care personnel should be a part of treatment, as problems in 
functional capacity are easier to evaluate in a home setting than in the doctor’s 
practice. Some of the problems in functional capacity can be quite easily corrected, 
such as reduced vision. The reasons for the functional capacity limitations of the 
patients should be evaluated individually and comprehensively.  
 
Despite the symptoms related to their disorder and reductions in functional capacity, 
patients with psychotic disorder are still relatively satisfied with their well-being, 
which is a positive thing. There is a discrepancy between subjective HRQoL and 
objective disability in people with schizophrenia. It should be taken into account 
when the results of HRQoL tests are used for health policy or health economics 
purposes. Because current generic health utility instruments are not the best possible 
means of measuring the HRQoL of people with psychotic disorder, Brazier (2010) 
has suggested that a new psychotic-specific preference-based measure should be 
developed.  
 
People with psychotic disorder need information about healthy lifestyles, and 
community psychiatric institutions could offer nutrition courses and exercise 
programmes, which could improve social contacts as well (Roick et al., 2007). 
 
6.5 Implications for future research 
 
People with schizophrenia have reduced vision, compared to the general population, 
and the reasons for it may be numerous. To find out the causes of the reduced visual 
acuity of people with psychotic disorder, studies that include a thorough 
ophthalmologic assessment are needed. 
 
To evaluate the reasons for mobility limitations, e.g. difficulties in walking and 
climbing stairs, there should be research on musculoskeletal disorders and diseases 
in persons with psychotic disorders. Although general medical conditions in persons 
with psychotic disorders have received a great deal of attention in recent years, this 
has been a neglected area.  
 
Longitudinal studies are needed to understand the development of reduced 
functional capacity, such as visual impairment, mobility limitations and decreases in 
muscle strength, ADL and IADL. This demands studies that follow the functioning 
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of people with first-episode psychosis. It is important to find out, how much and 
what kinds of difficulties are already present in the first phases of the disorder, what 
are the factors that contribute to the decline in functional capacity and which are the 
most effective forms of rehabilitation. 
 
Since current instruments for measuring health-related quality of life do not provide 
reliable information about the disability associated with psychotic disorders, new 
psychosis-specific preference-based measures should be created.  
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7 Conclusions 
Based on the results of the present study, people with psychotic disorder and 
especially with schizophrenia, have a significantly lower level of functioning than 
the general population. Their limitations are considerable and appear in all levels of 
functional capacity that were investigated in this study: vision, mobility, everyday 
functioning and quality of life. Schizophrenia was associated with by far the most 
severe functional limitations, whereas persons with affective psychoses did not 
differ from the remaining study population in many of the functions examined. 
People with schizophrenia and ONAP had problems in almost all areas in functional 
capacity. It has been previously known that people with psychotic disorder have 
decreases in functioning, but this study showed the large magnitude of the various 
problems compared to the general population of the same age.  
 
Some problems that we found could often be easily corrected, like problems in 
visual acuity. It is important to include the assessment of visual acuity in the annual 
medical examinations of patients with chronic psychotic disorders, and patients 
should also receive help in acquiring glasses.  
 
The everyday functioning of people with psychotic disorder is studied extensively, 
but one important factor, mobility, has not been widely studied. Mobility limitations 
are one of the key determinants of functional disability in the general population, 
and therefore the high prevalence of mobility limitations in persons with 
schizophrenia and other non-affective psychoses was alarming. Physical activity 
should be one area of rehabilitation in persons with psychotic disorder, and the 
causes of mobility limitations should be carefully assessed.  
 
Simple self-report scales are useful in clinical care. However, some patients 
overestimate their functional capacity, and therefore real-life functioning should be 
also assessed by home visits and other more intensive measurements. Improvement 
of everyday functioning is one of the key goals of rehabilitation of patients with 
psychotic disorders. In order to achieve this goal, it is important to assess carefully 
the causes of the limitations of each patient. 
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